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actin-related proteins (Arps) 7 and 9 through an N-terminal helicase/SANT-associated (HSA) domain. An
additional auxiliary subunit, Rtt102, co-purifies with Arp7/9. In this dissertation, I sought to understand how
Arp7/9 binding to the HSA domain of Sth1 regulates the structure and function of the central ATPase
domain, and how this regulation is modulated by Rtt102. Using Isothermal Titration Calorimetry (ITC),
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function, I designed a novel biochemical assay to test for the effects of Arp7/9-binding on intramolecular
interactions within Sth1. This approach revealed that two conserved sequences, Protrusion-1 (P1) within the
ATPase domain and a region adjacent to the HSA domain known as the post-HSA (pHSA) domain, interact
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Rtt102-dependent manner. Fluorescence anisotropy experiments further showed that the weakening of
P1-pHSA interaction by Rtt102-Arp7/9 reduces the affinity of the ATPase domain for DNA. Taken together,
Rtt102 thus emerges as an important factor that stabilizes Arp7/9, allowing it to modulate regulatory intra-
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work establishes a novel molecular mechanism for regulation of the RSC remodeler.
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ABSTRACT 
ARP7/9 REGULATES THE STRUCTURE AND FUNCTION OF THE STH1 ATPASE 
IN AN RTT102-DEPENDENT MANNER 
Bengi Turegun 
Dr. Roberto Dominguez 
Chromatin remodeling complexes (remodelers) alter chromatin structure to 
regulate access to DNA.  Remodelers belong to four families, but each are 
assembled around a catalytic subunit, featuring a conserved, DNA-dependent 
ATPase domain flanked by family-specific domains.  These can intra-molecularly 
interact with the ATPase domain to regulate its function and can also recruit auxiliary 
subunits for additional regulation.  Sth1, the catalytic subunit of the yeast SWI/SNF-
family remodeler RSC, recruits a heterodimer of actin-related proteins (Arps) 7 and 9 
through an N-terminal helicase/SANT-associated (HSA) domain.  An additional 
auxiliary subunit, Rtt102, co-purifies with Arp7/9.  In this dissertation, I sought to 
understand how Arp7/9 binding to the HSA domain of Sth1 regulates the structure 
and function of the central ATPase domain, and how this regulation is modulated by 
Rtt102.  Using Isothermal Titration Calorimetry (ITC), Small angle X-ray scattering 
(SAXS) and X-ray crystallography. I discovered that Rtt102 binds with nanomolar 
affinity to stabilize a compact conformation of the Arp7/9 heterodimer, which is 
required for full binding to the HSA domain and formation of a stable complex with 
the ATPase domain.  The crystal structure of the Rtt102-Arp7/9 complex reveals that 
ATP binds to Arp7 to help stabilize the compact conformation of Rtt102-Arp7/9 
required for tight association with the HSA domain.  To correlate these findings to 
 vi 
remodeler function, I designed a novel biochemical assay to test for the effects of 
Arp7/9-binding on intramolecular interactions within Sth1.  This approach revealed 
that two conserved sequences, Protrusion-1 (P1) within the ATPase domain and a 
region adjacent to the HSA domain known as the post-HSA (pHSA) domain, interact 
directly with each other.  Binding of Arp7/9 to the HSA domain weakens this 
interaction in an Rtt102-dependent manner.  Fluorescence anisotropy experiments 
further showed that the weakening of P1-pHSA interaction by Rtt102-Arp7/9 reduces 
the affinity of the ATPase domain for DNA. Taken together, Rtt102 thus emerges as 
an important factor that stabilizes Arp7/9, allowing it to modulate regulatory intra-
molecular interactions within Sth1 and thereby control DNA binding to the ATPase 
domain.  As such, this work establishes a novel molecular mechanism for regulation 
of the RSC remodeler.  
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"Anything found to be true of E. coli must also be true of elephants." 
- Jacques Monod
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CHAPTER 1: Introduction 
 2 
1.1 – An introduction to chromatin-remodeling complexes 
 In eukaryotic cells, DNA is packaged into nucleosomes, which constitute the 
basic building block and fundamental repeating unit of chromatin (Kornberg, 1974).  
The core of the nucleosome contains two copies of each of the four core histone 
proteins: H2A, H2B, H3, and H4.  The histone core of the nucleosome is arranged 
such that a central histone H3/H4 tetramer is flanked on both sides by a H2A/H2B 
dimer, with 147 base pairs (bp) of negatively-charged DNA wrapped around the 
resulting positively-charged histone octamer (Luger et al., 1997).  Through a series 
of higher-order inter-nucleosome interactions, each cell is eventually able to package 
2 meters of linear DNA into the 10-micron nucleus (Halverson et al., 2014).  While 
this is a remarkable organizational feat, many fundamental cellular processes 
depend on the ability of regulatory proteins and complexes to access DNA in a 
timely manner.  Thus, it would appear that the tight packaging of DNA within the 
nucleus represents a significant barrier to proper cellular function.  However, a more 
appropriate interpretation is that chromatin structure presents an opportunity for the 
tight regulation of DNA exposure during fundamental cellular processes such as 
DNA replication, transcription, and DNA repair. 
 To effectively regulate these important cellular events, cells employ two 
classes of large protein complexes to control the ability of regulatory proteins to 
interact with particular DNA sequences or nucleosomes.  The first group, generally 
termed chromatin-modifying complexes, covalently modifies the side chains of 
specific residues within the core histones; identified modifications include 
acetylation, phosphorylation, methylation, sumoylation, and ubiquitination (Peterson 
 3 
and Laniel, 2004).  These covalent groups can help regulate chromatin assembly 
and gene expression in two major ways.  First, these post-translational modifications 
can alter the strength of the interactions between the highly basic histone tails and 
the negatively-charged phosphate backbone of DNA.  Secondly, these modifications 
can serve as signals for the specific recruitment of additional regulatory protein 
factors (Bannister and Kouzarides, 2011; Suganuma and Workman, 2011).  For 
example, histone acetyl-transferases (HATs) are large, multi-subunit complexes 
whose catalytic subunit acetylates conserved lysine residues in the highly basic N-
termini of histones H3 and H4 (McCullough and Marmorstein, 2016).  As a result of 
histone acetylation, the highly electrostatic DNA-histone interactions that stabilize 
the structure of the nucleosome are weakened.  This can lead to a less compact 
chromatin structure in which the DNA, wound less tightly around the histone 
octamer, is more accessible to regulatory proteins (Talbert and Henikoff, 2016).  
Moreover, histone acetylation can also serve as a platform through which regulatory 
proteins and complexes are recruited to specific chromatin regions.  An important 
example of proteins that can be recruited in this way is the second major class of 
chromatin-regulatory complexes, known as chromatin-remodeling complexes 
(remodelers) (Chatterjee et al., 2011; Kasten et al., 2004).   
 The first chromatin-remodeling complex was discovered in the budding yeast 
Saccharomyces cerevisiae.  This historic finding was the result of multiple genetic 
studies, spanning the mid 1980s to the early 1990s, in which several genes essential 
for mating type switching (SWI) and growth in glucose-limited conditions (sucrose 
non-fermenting, SNF) were identified (Breeden and Nasmyth, 1987; Hirschhorn et 
 4 
al., 1992; Neigeborn and Carlson, 1984; Stern et al., 1984).  The set of genes whose 
deletion produced these phenotypes was deduced to encode for the components of 
a large protein assembly (Peterson and Herskowitz, 1992), appropriately named the 
SWI/SNF complex.  Intriguingly, the defects in transcription and nucleosome 
organization at the SUC2 promoter, which controls the expression of the invertase 
enzyme and is thus required for growth on sucrose, that arise from the mutation of 
SWI/SNF subunits could be rescued by decreasing the gene dosage of histones 
H2A and H2B (Clark-Adams et al., 1988; Hirschhorn et al., 1992).  A link was thus 
established between the SWI/SNF complex and the packing of regulatory DNA 
elements into nucleosomes.  This suggested that the SWI/SNF complex may 
function by antagonizing transcriptionally repressive chromatin structure at key 
promoters (Sudarsanam and Winston, 2000).  Extensive work since these 
pioneering studies has firmly established remodelers as a large family of multi-
subunit complexes that regulate gene expression and genome maintenance through 
non-covalent, dynamic effects on chromatin structure (Clapier and Cairns, 2009). 
 Remodelers vary in their subunit composition, but they all assemble around a 
catalytic subunit featuring a conserved helicase superfamily 2 (SF2) ATPase domain 
(Fairman-Williams et al., 2010; Flaus et al., 2006; Singleton et al., 2007).  This DNA-
dependent ATPase domain consists of two recA-like subdomains, with the 
characteristic sequence motifs that together constitute the nucleotide- and DNA-
binding sites located at the interface between subdomains (Durr et al., 2005; Hauk 
and Bowman, 2011; Hauk et al., 2010; Thoma et al., 2005; Xia et al., 2016; Yan et 
al., 2016) (Figure 1.1).  The two recA-like subdomains are flexible with respect to  
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Figure 1.1 – The recA subdomains of the ATPase domain are flexible. 
Shown here are the crystal structures of the Rad54 remodeling enzyme from 
zebrafish (PDB accession code 1Z3I) (Thoma et al., 2005) and the thermophilic 
archaeon Sulfolobus solfataricus (PDB accession code 1Z63) (Durr et al., 2005).  
The seven classical helicase motifs which control DNA-dependent ATP hydrolysis 
are highlighted in cyan, while the subdomains within the ATPase are color-coded. 
The nomenclature is as follows: recA-N and recA-C, N- and C-terminal recA 
domains of the ATPase; P1 and P2, protrusion-1 and protrusion-2.  Note that P2 
will not be discussed further.  However, it is highlighted here to provide a clear 
representation of the drastically different conformations the ATPase domain can 
assume.  As such, the inter-subdomain orientation differs by nearly 180° between 
the two structures.  The helicase motifs are thus only aligned in an active 
conformation across the inter-recA cleft in the zebrafish structure.  Note also that 
the DNA-bound structure was also solved in the absence of DNA, with no 
observed changes in conformation.   
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their relative orientations, allowing them to co-operate in hydrolyzing ATP in a DNA-
dependent manner to propel DNA translocation and the accompanying rupture of 
histone-DNA contacts (Clapier and Cairns, 2014; Narlikar et al., 2013).  In utilizing 
the energy released upon ATP hydrolysis, remodelers are able to catalyze various 
changes in chromatin structure, including histone octamer sliding, ejection and 
histone subunit exchange (Dechassa et al., 2010; Lorch et al., 2011; Mizuguchi et 
al., 2004; Parnell et al., 2008; Saha et al., 2002; Yang et al., 2007) (Figure 1.2). 
The diverse chromatin restructuring outcomes that can arise from ATP 
hydrolysis by the catalytic subunit are mediated by additional domains, referred to 
here as auxiliary domains.  N- and C-terminal to the central ATPase core, these 
regions frequently serve as a platform for recruitment of other remodeler subunits, 
generally known as auxiliary subunits. Indeed, chromatin-remodeling complexes are 
classified into four major families (SWI/SNF, INO80, CHD1, ISWI) based on the 
domain architecture (Figure 1.3) and resulting subunit composition of their catalytic 
subunits.  It is important to note that there are also remodelers, known as orphan 
remodelers, whose sequences N- and C-terminal to the central ATPase domain are 
poorly characterized.  Nevertheless, for all remodelers, auxiliary domains can serve 
as important regulatory modules that can impart specific functions onto catalytic 
subunits which share a highly conserved catalytic domain.  
  
 
 
 7 
 
 
 
 
 
 
Figure 1.2 – Activities performed by chromatin-remodeling complexes. 
DNA-dependent ATP hydrolysis by the catalytic subunit fuels DNA translocation, 
which can lead to nucleosome sliding and ejection.  Certain remodelers also 
feature subunits that can recognize specific histone variants and thus catalyze 
their deposition or removal from nucleosomes.  Adapted from (Clapier and Cairns, 
2009) 
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Figure 1.3 – Domain architecture of the four main remodeler families.   
The nomenclature is as follows: HSA, helicase-SANT-associated domain; pHSA, 
post-HSA domain; recA-N and recA-C, N- and C-terminal recA domains of the 
ATPase; P1, protrusion-1; SnAc, Snf2 ATP coupling; B, bromodomain; AutoN, N-
terminal autoinhibitory region; NegC, negatively regulates coupling of ATP 
hydrolysis to DNA translocation; HSS, HAND-SANT-SLIDE domain; C, 
chromodomain; DBD, DNA-binding domain.  Note that the combination of HSA, 
pHSA, and P1 is unique to the SWI/SNF and INO80 families.  Adapted from 
(Manning and Peterson, 2013). 
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1.2 – Regulation of chromatin-remodeling complexes  
While chromatin-remodeling complexes differ in the domain architecture of 
their catalytic subunits, a universal theme in remodeler function has emerged: 
auxiliary domains, by directly interacting with the ATPase domain and/or 
nucleosomal substrates, can regulate the structure and function of the central 
ATPase domain.  The orphan remodeler CSB, the mutation of which is a hallmark of 
Cockayne syndrome, serves as a strong introductory example of these regulatory 
themes.  Here, a region N-terminal to the catalytic ATPase domain antagonizes the 
UV-dependent chromatin association of the remodeling enzyme, as well as its DNA-
dependent ATPase activity (Lake et al., 2010).  Similarly, in the Rad54 remodeling 
enzyme, deletion of a flanking sequence N-terminal to the central ATPase domain 
leads to a loss of nucleosome remodeling activity (Alexiadis et al., 2004). 
The auxiliary domains within the catalytic subunits of the four conventional 
remodeling families also participate in important regulatory interactions.  In CHD-
family remodelers, the tandem chromo-domains N-terminal to the central ATPase 
core of the Chd1 catalytic subunit specifically bind tri-methylated H3K4 (Brehm et al., 
2004; Flanagan et al., 2005), and in doing so provide a general mechanism to target 
the remodeler to transcriptionally active regions of chromatin (Schneider et al., 
2004).  An additional regulatory function of the tandem chromodomains was 
revealed upon crystallization of yeast Chd1.  The structure revealed that the 
chromodomains feature a negatively-charged patch which mimics the DNA 
backbone, and are thus able to interact intra-molecularly across the cleft between 
the RecA lobes of the ATPase domain, blocking the DNA-binding surface and 
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locking the ATPase in an inactive conformation (Hauk et al., 2010).  Chd1 also 
contains a C-terminal, auxiliary DNA-binding domain (DBD) that is required for 
interaction with extra-nucleosomal (linker) DNA, nucleosome binding, and histone 
octamer sliding activity (Ryan et al., 2011; Sharma et al., 2011; Stockdale et al., 
2006).  Therefore, auxiliary domains both N- and C-terminal to the central ATPase 
domain can have powerful regulatory capacity.  
Similar to the CHD1 family, the C-terminus of ISWI remodeler catalytic 
subunits bears an alpha-helical region known as the HAND-SLANT-SLIDE domain 
(Grune et al., 2003).  This module recognizes linker DNA and thus supplements the 
nucleosome remodeling activities of the catalytic subunit by enhancing its affinity for 
nucleosomes (Dang and Bartholomew, 2007; Mueller-Planitz et al., 2013).  ISWI 
remodelers are further regulated by two additional auxiliary domains: AutoN and 
NegC, N- and C-terminal to the ATPase domain, respectively (Clapier and Cairns, 
2012).  The NegC domain prevents the coupling of ATP hydrolysis to DNA 
translocation (Clapier and Cairns, 2012).  In contrast, the AutoN domain interacts 
with both RecA lobes to lock the ATPase in an inactive conformation (Yan et al., 
2016); part of this auto-interaction surface is comprised of a basic patch of amino 
acids in the AutoN domain that mimics the positively-charged N-terminal tail of 
histone H4, which is required for nucleosome sliding activity (Clapier and Cairns, 
2012; Clapier et al., 2001; Hamiche et al., 2001).  Thus, the H4 tail likely activates 
ISWI by out-competing AutoN for the interaction surface on the ATPase domain, 
thereby relieving this auto-inhibition (Yan et al., 2016).  In this way, the AutoN region 
of ISWI is similar in general mechanism to the tandem chromodomains of Chd1, as 
 11 
both mimic nucleosomal substrates to interact directly with their adjacent ATPase 
domains and suppress catalytic activity. 
The domain architecture of the catalytic subunits of SWI/SNF- and INO80-
family remodelers differs from that of the CHD and ISWI families.  In SWI/SNF 
remodelers, the SnAc (Snf2 ATP coupling) domain, C-terminal to the central ATPase 
domain, interacts with the C-terminal RecA lobe and positively regulates the catalytic 
activity of the ATPase domain (Sen et al., 2011; Xia et al., 2016).  Moreover, the 
SnAC domain is also capable of interacting with histones and thereby promoting the 
coupling of ATP hydrolysis to nucleosome sliding (Sen et al., 2013).  Further C-
terminal to the SnAC in the catalytic subunit of SWI/SNF-family remodelers lies a 
bromodomain.  While this region does not participate in an intra-molecular 
interaction with the ATPase domain, the bromodomain specifically binds 
nucleosomes whose histones have been acetylated, and can thereby help anchor 
SWI/SNF remodeling complexes to the promoters of genes during transcriptional 
activation (Hassan et al., 2002). 
N-terminal to the ATPase domain, the catalytic subunits of both the SWI/SNF 
and INO80 remodeler families feature a helicase-SANT-associated (HSA) domain, 
followed immediately by a post-HSA (pHSA) domain.  While little is known about the 
role of the HSA-pHSA region in regulation of remodeler function, a seminal study 
has definitively identified the HSA domain as the platform through which actin and 
actin-related proteins (Arps) are recruited to remodelers (Szerlong et al., 2008).  
Actin and Arps, which will be discussed at length in the following section, are 
representative of another important way in which auxiliary domains of the catalytic 
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subunit can regulate the function of their host remodelers: the recruitment of auxiliary 
subunits. 
While the role of many auxiliary subunits is unknown, it is becoming 
increasingly clear that they can participate in modulation of the activity of the 
catalytic subunit.  ISWI-family remodelers are prime examples of this regulatory 
capacity of auxiliary subunits.  Specifically, reconstitution studies using recombinant 
proteins revealed that the nucleosome sliding activity of SNF2h, the human ortholog 
of the ISWI catalytic subunit, is markedly enhanced when assembled as a complex 
with auxiliary subunit ACF1 (He et al., 2008).  An analogous effect is observed in the 
Drosophila ISWI complex, where addition of the auxiliary subunit NURF301 also 
increases the nucleosome sliding efficiency of the catalytic subunit (Xiao et al., 
2001).  A similar biochemical reconstitution analysis of the human SWI/SNF complex 
revealed that the function of its catalytic subunit, Brg1, is also subjected to regulation 
by auxiliary subunits.  Specifically, auxiliary subunits INI1, BAF170, and BAF155 
substantially increase the DNA-dependent ATPase and nucleosome sliding activities 
of Brg1 (Phelan et al., 1999).  Lastly, in INO80-family remodelers, the hexameric 
helicases Rvb1 and Rvb2 are essential for ATP-dependent remodeling activity on a 
nucleosome array (Jonsson et al., 2004).  Thus, the ability of auxiliary subunits to 
regulate the activity of the catalytic subunit appears to be a common feature across 
the different remodeler families. 
In addition to being able to regulate the catalytic activity of the ATPase core, 
auxiliary subunits can also contribute to the function of their host complexes by 
directly interacting with nucleosomal substrates.  Returning to the INO80 family, this 
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group of remodelers contains the SWR1 sub-family, which has a specific role in 
exchanging histone H2A for the H2A.Z variant (Kobor et al., 2004; Krogan et al., 
2003; Mizuguchi et al., 2004).  This histone variant exchange is an important event 
in transcriptional regulation, as H2A.Z-containing nucleosomes are less stable, and 
thus their enrichment at promoters contributes to transcriptional activation (Jin and 
Felsenfeld, 2007; Weber and Henikoff, 2014).  A yeast SWR1 complex lacking 
auxiliary subunit Swc2 is deficient for H2A.Z exchange; indeed, Swc2 binds directly 
to H2A.Z (Wu et al., 2005).  A similar method of regulation by an auxiliary subunit is 
observed in the displacement of histone H2A/H2B dimers by SWI/SNF-family 
remodelers (Bruno et al., 2003).  Specifically, auxiliary subunit Swi3 of the yeast 
SWI/SNF complex bears an N-terminal histone-binding region that is required for 
H2A/H2B dimer ejection (Yang et al., 2007).  Moreover, loss of this subunit has no 
effect on the ATPase activity of the complex, indicating that modulation of the 
ATPase domain and direct interaction with histones are two distinct regulatory 
mechanisms of auxiliary subunits.  Thus, the examples of Swc2 and Swi3 provide a 
mechanistic basis for understanding how auxiliary subunits, by interacting directly 
with particular nucleosomal substrates, can mediate the functional specificity of 
remodelers. 
Intuitively, the ability of certain auxiliary subunits to interact with histones 
should also help them target their host complexes to specific regions of chromatin.  
As an example, auxiliary subunit Snf5 is dispensable for the ATPase activity of 
mammalian SWI/SNF complexes, but its loss leads to a reduction in enrichment of 
the catalytic subunit Brg1 at promoters; this results in changes in the nucleosome 
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occupancy at these promoters, with significant up-regulation of many important 
genes controlling cellular growth (Tolstorukov et al., 2013).  It is thus not surprising 
that loss of the gene encoding for Snf5 is associated with cancer (Wilson and 
Roberts, 2011).  In conclusion, it is clear that auxiliary domains and subunits play 
important roles in controlling the enzymatic activities and nucleosome-targeting of 
their host remodelers.  It is within this conceptual framework that an understanding 
of the roles that actin and Arps play in SWI/SNF and INO80-family remodelers has 
begun to emerge.  
1.3 – Beyond the cytoplasm: roles for nuclear actin and Arps 
 Actin has been extensively studied and is thus well understood in the context 
of its essential roles in the cytoplasm as a fundamental component of the 
cytoskeleton.  Here, the regulated transition of G-actin in and out of filaments is 
crucial for cell motility and division, vesicle trafficking, endocytosis, and the 
maintenance of cell morphology (Bugyi and Carlier, 2010; Dominguez, 2009; 
Kaksonen et al., 2006; Pollard and Borisy, 2003).  Actin dynamics in the cytoplasm 
are regulated by a wide variety of actin-binding proteins, including actin-related 
proteins (Arps).  The Arps (Arp1-11), numbered based on decreased sequence 
identity (52-17%) to actin, are a protein family that shares the canonical four 
subdomain actin-fold (Figure 1.4), but they differ in their subcellular localization (Dion 
et al., 2010).  Specifically, Arps 1-3 and 10-11 function in the cytoplasm, while Arps 
4-9 are found in the nucleus.  As is the case with actin, our understanding of  
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Figure 1.4 – Structure and conservation of actin-related proteins. 
The crystal structure of budding yeast actin (PDB accession code: 1YAG) is 
shown, with the four subdomains labeled (Vorobiev et al., 2003).  The coloring 
scheme is based on the conservation between actin and the eleven Arps. 
Conservation scores were projected onto the actin structure by the Consurf server 
(Ashkenazy et al., 2010).  The bound ATP is colored in black.  Note the high 
conservation of the surrounding pocket.    
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cytosolic Arps is much more advanced when compared to the study of their nuclear 
counterparts. 
In the cytoplasm, Arp2 and Arp3 are key components of the seven-subunit 
Arp2/3 complex, which controls the nucleation of branched actin filaments at the 
cell’s leading edge in a highly regulated manner (Goley and Welch, 2006; Pollard, 
2007).  As such, the Arp2/3 complex is a crucial regulatory factor in the cytoskeleton, 
and its mis-regulation can have disastrous consequences.  In fact, the Arp2/3 
complex and associated nucleation-promoting factors that stimulate its activity in 
response to cellular signals are important for the formation of actin-rich membrane 
protrusions, known as invadopodia.  These are crucial for invasion of the extra-
cellular matrix and metastasis (Nurnberg et al., 2011; Yamaguchi et al., 2005).  
Similar to Arps 2 and 3, Arp1 and Arp10 (known as Arp11 in vertebrates) are 
members of an important cytoskeletal assembly: the dynactin complex (Gill et al., 
1991).  Dynactin is a large, 23-subunit complex which regulates the dynein motor, 
thereby playing an important role in cargo transport along microtubule filaments 
(Kardon and Vale, 2009; Urnavicius et al., 2015).  In fact, mutations in the dynactin 
complex can lead to a variety of neurodegenerative disease states (Schiavo et al., 
2013).  Thus, a unifying feature of cytosolic Arps is their presence in specific pairs 
within important protein complexes that regulate the dynamics of the cytoskeleton 
and the function of associated molecular motors.  Indeed, this paradigm can be 
extended to the nucleus, where actin and Arps, often in specific pairs, have emerged 
as key components of complexes that regulate gene expression. 
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Although there has been a recent surge in evidence supporting the presence 
of and key roles for actin filaments in the nucleus (Baarlink et al., 2013; Belin et al., 
2015; Grosse and Vartiainen, 2013; Miyamoto et al., 2011), nuclear actin is chiefly 
monomeric and widely accepted to be involved in the regulation of transcription.  A 
classical and well-studied example of monomeric actin’s role in transcription is 
through its regulation of the serum response factor (SRF) transcription factor.  When 
serum elicits actin polymerization in the cytoplasm, the SRF co-activator MAL is 
freed from its inhibitory interactions with G-actin and can thus be shuttled to the 
nucleus to activate SRF.  Conversely, under serum-starved conditions, actin-bound 
MAL in the nucleus is prevented from associating and thus activating SRF (Miralles 
et al., 2003; Vartiainen et al., 2007).  In addition to associating with transcription 
factors, actin also functions in transcriptional regulation by directly interacting with 
RNA polymerases (de Lanerolle and Serebryannyy, 2011; Grummt, 2006).  In fact, 
interaction with actin is required for the activity of RNA polymerases I (Fomproix and 
Percipalle, 2004; Philimonenko et al., 2004), II (Hofmann et al., 2004), and III (Hu et 
al., 2004).  As alluded to earlier, the packaging of DNA into nucleosomes constitutes 
a steric challenge to this transcriptional machinery.  Thus, another context in which 
nuclear actin and Arps participate in transcriptional regulation is as stoichiometric 
subunits of SWI/SNF- and INO80-family chromatin-remodeling complexes (Kast and 
Dominguez, 2011). 
Arps were first discovered as stable components of chromatin-remodeling 
complex through mass spectrometry analysis of the two budding yeast SWI/SNF-
family remodelers, RSC and SWI/SNF.  These pioneering studies identified Arp7 
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and Arp9 as shared components of the two complexes  (Cairns et al., 1998; 
Peterson et al., 1998).  Neither Arp7 nor Arp9 is present in mammals, and thus the 
human ortholog of SWI/SNF, the BAF complex, instead contains actin and BAF53 
(the human ortholog of Arp4) (Zhao et al., 1998).  Interestingly, the actin/Arp4 pair is 
a shared feature of several remodelers.  For example, mass spectrometry analysis 
of the first INO80 complex purified from yeast identified actin, Arp4, Arp5, and Arp8 
as subunits of the remodeler (Shen et al., 2000).  All of these subunits are retained 
in the human version of the complex (Jin et al., 2005).  Actin and Arp4 are also 
present in the INO80-family SWR1 complex, although Arp8 is absent from this 
remodeler and Arp6 is present in lieu of Arp5 (Mizuguchi et al., 2004).  Interestingly, 
actin and Arp4 are also stoichiometric components of the NuA4 histone 
acetyltransferase complex (Galarneau et al., 2000), suggesting a more general role 
for this duo in the regulation of gene expression.   
The first clues that actin and Arps have important roles in remodeler function 
arose from early yeast genetics studies.  Arp4 is essential for yeast viability (Harata 
et al., 1994), although its presence in the INO80, SWR1, and NuA4 complexes 
makes it impossible to discern whether this phenotype is due to its role in chromatin-
remodeling, histone acetylation, or both processes.  Furthermore, deletion of the 
Arp7 or Arp9 gene in a W303 strain of budding yeast results in impaired growth 
phenotypes that closely resemble those observed upon deletion of other SWI/SNF 
subunits, suggesting that these Arps have important roles in regulating the 
chromatin-remodeling and transcriptional regulation functions of the RSC and 
SWI/SNF complexes in vivo (Cairns et al., 1998; Peterson et al., 1998).  Therefore, 
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actin and Arps are important components of chromatin-remodeling complexes, 
although how they regulate the function of their host complexes remains to be 
elucidated. 
In order to propose hypotheses for how actin and Arps regulate remodeler 
structure and function, it is first necessary to establish a mechanistic understanding 
of how they are incorporated into their host complexes.  Biochemical studies have 
begun to shed light onto this important question.  One such investigation revealed 
that Arp7 and Arp9 form a stable heterodimer (Arp7/9), and that each Arp requires 
the other to be loaded into the RSC and SWI/SNF complexes (Szerlong et al., 2003), 
suggesting that the hetero-dimer is the functional unit.  Furthermore, Arp7/9 co-
purifies with an additional subunit, Rtt102, although its function is unknown (Szerlong 
et al., 2008).  Interestingly, like Arp7/9, Rtt102 is a member of both RSC and 
SWI/SNF complexes (Lee et al., 2004).  Furthermore, similar to the loss Arp9 in a 
W303 genetic background, Rtt102 knockout in yeast elicits a severe growth 
phenotype under glycerol as a carbon source (Graumann et al., 2004). Given the 
similar consequences of Rtt102 and Arp9 loss, it is possible that Rtt102 may 
facilitate the loading of Arp7/9 into RSC and SWI/SNF, and that Rtt102-Arp7/9 may 
thus constitute an important regulatory module.  
  Consistent with the general theme of actin and Arps functioning in pairs (or 
trios), the deletion of Arp8 also prevents actin and Arp4 from associating with the 
INO80 complex (Shen et al., 2003).  Furthermore, deletion of a region N-terminal to 
the ATPase domain of the Ino80 catalytic subunit similarly results in the loss of actin, 
Arp4, and Arp8 from the complex (Shen et al., 2003).  A similar N-terminal truncation 
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of the Swr1 catalytic subunit resulted in the loss of actin and Arp4 from the Swr1 
complex (Wu et al., 2005).  Thus, actin and Arp4 form a structural unit which binds to 
a region N-terminal to the central ATPase domain, and which may have general 
regulatory roles, with the addition of Arp8 conferring functional specialization to the 
INO80 complex.  Interestingly, these studies established that Arp5 and Arp6 
associate with the INO80 and SWR1 complexes, respectively, independently of the 
actin/Arp4 module.  In fact, these Arps interact with the Rvb hexameric helicases, 
which themselves are recruited to the INO80-family remodelers through interaction 
with a large insertion separating the two recA lobes of the catalytic ATPase domain 
(Figure 1.3) (Chen et al., 2011; Jonsson et al., 2004; Tosi et al., 2013; Wu et al., 
2005).  However, since the presence of this long insertion between the recA 
domains and these additional Arps are unique to the INO80 family, and thus not 
present in SWI/SNF-family remodelers, Arp5 and Arp6 will not be interrogated 
further in this dissertation. 
To begin to probe the mechanisms through which actin and Arps may 
regulate their host remodelers, it is essential to understand how they are 
incorporated into their host complexes.  In 2008, an important study established a 
~70-aa region N-terminal to the ATPase domains, known as the helicase-SANT-
associated (HSA) domain, as the platform through which remodeler catalytic 
subunits, as well as the Eaf1 subunit of the NuA4 histone acetyltransferase complex, 
recruit Arp7/9 or actin/Arp4(/Arp8) to their host complexes (Szerlong et al., 2008).  
Overexpression of each affinity-tagged HSA domain in yeast was sufficient to pull-
down the cognate actin/Arp pair or trio.  Importantly, this domain is unique to the 
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actin/Arp-containing SWI/SNF and INO80 remodeler families.  Therefore, it is 
possible that the mechanisms through which actin and Arps regulate catalytic 
subunit structure and function may be similar in these two families.  However, 
whether or not additional auxiliary subunits, such as Rtt102 in yeast SWI/SNF-family 
remodelers, promote the efficient binding of actin/Arps to the HSA domain remains 
unclear. 
While the specific role of actin and Arps within remodelers is not fully 
understood, emerging evidence suggests that they, like the other auxiliary subunits 
discussed earlier, may regulate the ATPase activity of remodelers and may also play 
a role in nucleosome targeting.  Consistent with a role in targeting their host 
complexes to nucleosomes, Arp4 and Arp8 share the ability to interact with core 
histones in GST pull-down assays (Galarneau et al., 2000; Harata et al., 1999; Shen 
et al., 2003).  The case for the Arps playing a nucleosome-targeting role is further 
strengthened by the fact that Arp4 and Arp8, both in isolation and in a quaternary 
complex with actin and the HSA domain of the Ino80 catalytic subunit, bind 
mononucleomes with sub-micromolar affinity (Gerhold et al., 2012).  Furthermore, a 
negative-stain electron microscopy (EM) structure of the nucleosome bound on 
either face by Arp8 provides a structural basis for the ability of Arp8 to aid in 
nucleosome targeting of the INO80 complex (Saravanan et al., 2012).  Finally, an 
INO80 complex bearing a mutation in subdomain 2 at the pointed end of actin has a 
lower affinity for DNA and mononucleosomes than the wild-type complex (Kapoor et 
al., 2013).  Interestingly, the Arp7/9 hetero-dimer does not interact with nucleosomes 
(Szerlong et al., 2003), suggesting that this Arp module may instead regulate yeast 
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SWI/SNF-family remodelers through another mechanism, such as by modulating the 
structure and function of the catalytic ATPase domain. 
The first evidence that actin and Arps may modulate the ATPase activity of 
remodeler catalytic subunits arose from an early study of the human SWI/SNF 
remodeler.  Here, treatment with latrunculin B abolished the DNA-stimulated ATPase 
activity of the complex (Zhao et al., 1998).  Latrunculin B binds actin in its nucleotide-
binding cleft and thus prevents actin polymerization by sequestering actin monomers 
(Dominguez and Holmes, 2011).  Therefore, this finding was suggestive of an 
important role for monomeric actin in human SWI/SNF function. Similarly, a yeast 
INO80 complex lacking the actin-Arp4-Arp8 module is deficient for DNA binding, 
ATP hydrolysis, and nucleosome sliding (Shen et al., 2003).  In the case of the 
Arp7/9 hetero-dimer, RSC complexes lacking these Arps lose roughly half of their 
ATPase activity (Szerlong et al., 2008).  However, the molecular basis for these 
effects is largely unknown. 
A clue as to the potential regulatory mechanism for RSC was provided by 
genetic work which established that the lethality caused by dual deletion of Arp7 and 
Arp9 can be rescued by mutations in Sth1, the catalytic subunit of RSC (Szerlong et 
al., 2008).  These suppressor mutations localize to two specific domains: the post-
HSA (pHSA) domain and Protrusion 1 (P1).  The pHSA is a ~60 aa sequence 
immediately C-terminal to the HSA domain and is only found in the catalytic subunits 
of actin/Arp-containing remodelers.  P1 is an alpha-helical insertion within the N-
terminal recA lobe of the SF2-family ATPases (Figure 1.3).  It is critical to note that 
the pHSA-P1 combination is found only within the actin/Arp-binding INO80 and 
 23 
SWI/SNF remodeling families, and that the sequence conservation of these regions 
within each family is remarkably high.  As such, actin/Arps may make additional 
contacts with pHSA and P1 to regulate the ATPase domain.  An alternative 
interpretation is that, given the prevalence of auto-interactions between auxiliary 
domains with the ATPase core as a means for remodeler regulation, the pHSA and 
P1 regions may directly interact in an actin/Arp-dependent manner.  A major goal of 
this dissertation is to elucidate this regulatory mechanism.   
Any investigation into Arp function would be incomplete without considering a 
role for nucleotide binding to the Arps.  Indeed, the region of highest conservation 
within the Arp family is the actin-like ATP binding pocket (Figure 1.4).  Since the 
pocket forms at the interface between the two main domains, actin is unstable and 
thus unfolds in the absence of bound nucleotide (Kudryashov and Reisler, 2013).  In 
fact, important actin-binding proteins, such as profilin and cofilin, show clear 
preferences for specific nucleotide states (Dominguez and Holmes, 2011; dos 
Remedios et al., 2003).  Thus, ATP acts as a switch regulating actin filament 
dynamics: monomeric actin (free or profilin-bound) is incorporated into filament 
barbed ends in its ATP-bound state, followed by ATP hydrolysis and inorganic 
phosphate (Pi) release, which promotes cofilin binding and the dissociation of ADP-
bound monomers from filament pointed ends (Dominguez and Holmes, 2011; Korn 
et al., 1987).  In addition to actin, nucleotide plays a key role in regulating the 
function of cytosolic Arps.  For example, within the Arp2/3 complex, ATP binding and 
hydrolysis by both Arp2 and Arp3 are required for the activating conformational 
changes within the complex that facilitate filament nucleation (Dayel et al., 2001; 
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Goley et al., 2004; Le Clainche et al., 2001).  It thus seems reasonable to propose 
that nucleotide binding could possibly play an analogous role in regulating the 
function of nuclear Arps. 
In contrast to the cytosolic Arps, the role of nucleotide in modulating nuclear 
Arp function is unclear.  While the exposed surfaces of Arps have low sequence 
conservation with respect to actin, the high conservation in the ATP-binding pocket 
suggests that nuclear Arps share the ability to bind ATP.  This prediction was 
supported by recent structural work on Arp4 and Arp8.  In the case of Arp4, the 
crystal structure contains bound ATP co-purified from the bacterial host, indicative of 
tight ATP binding and a lack of ATP hydrolysis (Fenn et al., 2011).  Furthermore, 
attempts to express Arp4 mutants with mutations designed to disrupt ATP binding 
produced insoluble protein.  Interestingly, the ability of Arp4 to bind ATP has been 
suggested to promote its dissociation from the NuA4 complex (Sunada et al., 2005).  
Crystal structures of Arp8 similarly feature tightly bound ATP, although Arp8 does 
appear to have a low level of basal ATPase activity (Gerhold et al., 2012; Saravanan 
et al., 2012).   
Curiously, and in contrast to the Arps of the INO80 remodeler family, it has 
long been thought that neither Arp7 nor Arp9 bind or hydrolyze ATP.  This is due to 
the fact that when the duo was first discovered in RSC and SWI/SNF, mutations 
expected to disrupt the actin-like ATP-binding cleft in both Arps failed to elicit an 
observable phenotype in yeast (Cairns et al., 1998).  Recent crystal structures of 
Arp7/9, both in isolation (Lobsiger et al., 2014) and as part of a quaternary complex 
with Rtt102 and the HSA domain of Snf2 (Schubert et al., 2013) appear consistent 
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with this interpretation, since in both structures, neither Arp contains bound 
nucleotide.  However, this may well be due to the fact that these complexes were 
crystallized in the presence of high concentrations of phosphate and sulfate ions, 
which in both structures occupy the nucleotide-binding pockets of Arp7 and Arp9. 
Thus, the studies performed to date have not excluded the possibility that these Arps 
may bind ATP, and this gap must be addressed to fully understand their roles in 
yeast SWI/SNF-family remodelers.  
1.4 – Really sensational complex: RSC as a model system  
 Since actin and Arps are important components of several eukaryotic 
remodelers, it is necessary to carefully select a model system to study the 
mechanisms through which they interact with the catalytic subunit to regulate the 
function of their host complexes.  For several reasons, the yeast RSC complex 
emerges as a strong candidate.  First, the complex is essential for viability, as its 
catalytic subunit, Sth1, is required for mitotic growth (Cairns et al., 1996; Laurent et 
al., 1992).  Indeed, no other remodeler catalytic subunit in budding yeast has this 
phenotype.  Consistent with an essential function, each cell contains thousands of 
copies of RSC, which is an order of magnitude more than SWI/SNF (Cairns et al., 
1994; Cairns et al., 1996; Cote et al., 1994).  Furthermore, the RSC complex co-
immuno-precipitates with all three RNA polymerases (Soutourina et al., 2006), and 
controls the transcription of a variety of genes important for cell wall integrity and cell 
cycle control (Angus-Hill et al., 2001).  Thus, the RSC complex is of tremendous 
biological importance, making it an appropriate yeast remodeler to use as a model 
system to study the role of actin and Arps.  
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Given that RSC is essential for yeast survival, it is not surprising that 
malfunction of human orthologs is often linked to disease states, including 
cardiovascular disease and cancer.  Indeed, human SWI/SNF remodelers are 
essential for proper cardiovascular development and function (Bevilacqua et al., 
2014; Curtis et al., 2012; Davis et al., 2013; Dirkx et al., 2013; Gelb, 2013; Lei et al., 
2012; Lei et al., 2013; Li et al., 2013a; Li et al., 2013b; Mahmoud and Poizat, 2013; 
Mehrotra et al., 2013; Puri and Mercola, 2012; Willis et al., 2012; Xiao et al., 2016; 
Xu and Fang, 2012; Yuan et al., 2013).  Specifically, Brg1, the human ortholog of 
Sth1, has key roles in regulation of cardiovascular function under both normal 
physiological and disease states (Xu and Fang, 2012).  For example, Brg1 was 
shown to be necessary for the survival and differentiation of multipotent neural crest 
cells that are essential for mammalian cardiovascular development (Li et al., 2013b). 
Furthermore, Brg1 is upregulated in cardiomyocytes subjected to cardiac stress, and 
inducible mutation of Brg1 in mice results in significantly reduced cardiac 
hypertrophy (Hang et al., 2010).   
Similar to its critical roles in controlling proper cardiovascular development 
and function, the malfunction of human SWI/SNF complexes is associated with 
many different types of cancer (Biegel et al., 2014; Helming et al., 2014; Kadoch and 
Crabtree, 2015; Kadoch et al., 2013; Masliah-Planchon et al., 2015; Reisman et al., 
2009; Weissman and Knudsen, 2009; Wilson and Roberts, 2011).  Strikingly, 
mutations in SWI/SNF subunits occur at an incredibly high frequency of 19% across 
diverse types of tumors, with particularly high rates of mutation observed in ovarian, 
renal, liver, gastric, skin, and pancreatic cancer (Shain and Pollack, 2013).  Not 
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surprisingly, the conserved ATPase domain of the catalytic subunit Brg1 is frequently 
mutated in different cancers (Kadoch and Crabtree, 2015).  As such, the SWI/SNF 
complex is emerging as a new target in cancer drug discovery (Zinzalla, 2016). 
Therefore, the fundamental importance of Brg1 function in human health further 
strengthens the case that the yeast RSC complex is a strong model system to study 
the mechanisms through which the activities of remodeler catalytic subunit can be 
regulated by actin and Arps.  
A final consideration in the selection of a model system to study Arp function 
in remodelers is feasibility.  Specifically, a thorough structural, biophysical, and 
biochemical investigation of how Arp7/9 interacts with the catalytic subunit Sth1 to 
regulate the RSC remodeler would require significant amounts of protein.  Therefore, 
it is important that the ability to produce large amount of pure, recombinant proteins 
does not prove to be a limiting factor in this study.  It is thus encouraging that several 
important RSC subunits, including the Arps, Rtt102, and Sth1 derivatives, have been 
expressed in bacteria (Malik et al., 2011; Saha et al., 2005; Szerlong et al., 2008; 
Szerlong et al., 2003).  Another important fact to consider is that RSC is a ~2 
megadalton complex containing seventeen subunits, representing a potentially 
insurmountable obstacle to a recombinant approach to study how the Arps 
contribute to overall complex function.  A more reasonable strategy would thus be to 
focus on a minimal RSC complex, provided that it is functional.  Therefore, it is highly 
convenient that a sub-complex of RSC, consisting of Sth1, Arp7, and Arp9, has been 
shown to bind DNA and translocate along DNA in a force-resistant manner (Malik et 
al., 2011; Sirinakis et al., 2011).  As further proof that this subcomplex is functional, a 
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subcomplex of the related SWI/SNF remodeler, containing the catalytic subunit Snf2, 
Arp7, and Arp9, has identical catalytic activity to the whole complex (Yang et al., 
2007).  Therefore, the Sth1-Arp7/9 sub-complex of RSC represents an ideal model 
system for the elucidating of the mechanisms of actin and Arp function in chromatin-
remodeling complexes.  
1.6 – Purpose of study section 
A crucial theme has emerged in the study of remodeler function and 
regulation, namely that the flanking sequences N- and C-terminal to the central 
catalytic subunit, known as auxiliary domains, can regulate the function of the 
ATPase, either through direct interaction or by recruitment of auxiliary subunits to the 
host complex.  Presumably, auxiliary subunits can exert these effects by weakening 
these intra-molecular interactions.  I thus postulate that nuclear actin and Arps may 
regulate their host SWI/SNF and INO80-family remodelers by weakening the ability 
of the auxiliary HSA and pHSA domains to interact with the ATPase domain of the 
Sth1 catalytic subunit. (Figure 1.5).  In light of the genetic relationship between the 
pHSA domain, the P1 region, and the Arps, I propose that this regulatory interaction 
occurs between the pHSA and P1 domains.  The aim of this thesis is to test this 
hypothesis.  To do so, I will use a subcomplex of the yeast RSC remodeler, 
containing the catalytic subunit Sth1, Arp7/9, and Rtt102.  Whether or not relieving 
this intra-molecular interaction has an activating or inhibitory effect on the ATPase 
will be an important question addressed in this study.  Given the lethal phenotype of 
the dual deletion of Arps 7 and 9, I predict that binding of the Arps, and  
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Figure 1.5 – A hypothesis for the regulation of the RSC remodeler. 
In this dissertation, I will test the hypothesis that binding of Rtt102-Arp7/9 to the 
HSA domain relieves auto-inhibitory interactions within the Sth1 catalytic subunit 
mediated by two highly conserved regions, pHSA and P1.  In this model, once 
activated by the Arps, the affinity of Sth1 for DNA will be strengthened, resulting in 
a more active remodeler.  Though the study focuses on this four protein 
subcomplex of RSC, auxiliary subunits are represented here by grey ovals. 
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subsequent relief of the pHSA-P1 intra-molecular interaction leads to a more active 
remodeler.  Finally, given its ability to co-purify with the Arps, I hypothesize that any 
regulatory effect of Arp7/9 on the Sth1 ATPase may be Rtt102-dependent.  I will test 
these hypotheses using a diverse array of biochemical, biophysical, and structural 
techniques.  By addressing the critical lack of mechanistic understanding of 
remodeler regulation by actin and Arps, this dissertation will make a significant 
contribution to the field of remodeler study.    
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CHAPTER 2: Subunit Rtt102 controls the conformation of the 
Arp7/9 heterodimer and its interactions with nucleotide and the 
catalytic subunit of SWI/SNF remodelers 
 
 
 
The majority of this research was originally published in the Journal of Biological 
Chemistry (Turegun et al., 2013). Bengi Turegun, David J. Kast and Roberto 
Dominguez. Subunit Rtt102 controls the conformation of the Arp7/9 heterodimer and 
its interactions with nucleotide and the catalytic subunit of SWI/SNF remodelers. The 
Journal of Biological Chemistry. 2013; 288:35758-35768. © the American Society for 
Biochemistry and Molecular Biology.  The crystal structure is part of a manuscript 
which is currently under review at the Proceedings of the National Academy of 
Sciences. 
This work was supported by NIH R01 grant GM073791 to Roberto Dominguez. and 
American Heart Association pre-doctoral fellowship 14PRE19970011 to Bengi 
Turegun. I thank Dr. Matthew Benning (Bruker AXS) for help with crystallographic 
data analysis, Les Dutton for access to the CD spectrophotometer instrument in his 
laboratory. 
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2.1 – Overview 
Chromatin-remodeling complexes are assembled around a catalytic subunit 
that contains a central ATPase domain and flanking sequences that recruit auxiliary 
subunits.  The catalytic subunits of SWI/SNF-family remodelers recruit actin-related 
proteins 7 and 9 (Arp7/9) through a helicase-SANT-associated (HSA) domain N-
terminal to the ATPase domain.  Arp7/9-containing remodelers also carry the 
auxiliary subunit Rtt102, but the role of this subunit is poorly understood.  To address 
this gap in knowledge, I performed a thorough study of the binding of Arp7/9 to Sth1 
and ATP, and investigated how Rtt102 regulates these interactions.  Thus, I show 
that Rtt102 binds with nanomolar affinity to the Arp7/9 heterodimer and modulates its 
conformation and interactions with the ATPase subunit and nucleotide.  When bound 
to Rtt102, Arp7/9 interacts with a shorter segment of the HSA domain.  I also found 
that Arp7, Arp9 and Arp7/9 interact very weakly with ATP, but Rtt102 promotes high-
affinity ATP binding to a single site in the heterodimer.  The crystal structure of 
Rtt102-Arp7/9 with bound ATP shows that the nucleotide binds to Arp7 but not Arp9. 
ATP appears to play a structural role by stabilizing a closed-cleft conformation of 
Arp7.  Together, the biochemical and structural data establish a function for subunit 
Rtt102 as a stabilizing factor for the Arp7/9 heterodimer, enhancing its interaction 
with nucleotide and stabilizing a compact conformation of Arp7/9 that potentiates 
binding to the HSA domain. 
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2.2 – Bacterially expressed Arp7, Arp9, and Arp7/9 are properly folded 
The experiments performed here required large amounts of pure, 
recombinant proteins.  While E. coli-expressed actin is not properly folded, some 
nuclear Arps, including the Arp7/9 heterodimer, have been successfully expressed in 
this system (Fenn et al., 2011; Gerhold et al., 2012; Saravanan et al., 2012; 
Szerlong et al., 2003).  However, previous attempts to express Arp7 and Arp9 in 
isolation produced insoluble protein (Szerlong et al., 2003).  Here, I established the 
large-scale bacterial expression of Arp7 and Arp9, both individually and co-
expressed as a heterodimer (Figure 2.1A).  To verify that the proteins were properly 
folded, I first analyzed their secondary structure content by circular dichroism (CD), 
using the spectrum of muscle-purified actin as a reference.  The CD spectra of Arp7, 
Arp9, Arp7/9 and actin were all very similar (Figure 2.1B), and displayed the 
characteristic profile of a mixed alpha/beta fold, as expected for this family of 
proteins (Dominguez and Holmes, 2011; Schubert et al., 2013).  As a further control 
for proper folding, I also collected small-angle x-ray scattering (SAXS) data for Arp7, 
Arp9, and Arp7/9, and probed their tertiary structure by calculating their Kratky plots 
(Figure 2.1C).  These plots were all bell-shaped, which is characteristic of folded, 
globular proteins (Putnam et al., 2007).  I thus conclude that bacterially expressed 
Arp7, Arp9, and Arp7/9 are properly folded, and thus suitable for the ensuing 
experiments.   
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Figure 2.1 – Analysis of recombinant Arp7, Arp9, and Arp7/9. 
A) SDS-PAGE (12%) analysis of the following proteins and complexes: Rtt102, 
actin, Arp7, Arp9, Arp7/9, Rtt102-Arp7/9. B) Comparison of the circular dichroism 
spectra of actin, Arp7, Arp9 and Arp7/9 (color-coded). C) Comparison of the 
Kratky plots of Arp7, Arp9 and Arp7/9 (color-coded) collected at ~3 mg/mL 
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2.3 – The HSA domain is not sufficient for full binding of Arp7/9 
The minimal HSA domain (i.e. the minimal fragment required for binding of 
the Arps) was previously defined as comprising Sth1 residues Val-301 to His-359 
(corresponding to Snf2 residues Ala-579 to His-637), since co-expression of this 
fragment with Rtt102, Arp7, and Arp9 resulted in a stable quaternary complex that 
remains intact throughout nickel affinity and size-exclusion chromatography 
(Szerlong et al., 2008).  However, secondary structure prediction suggested that this 
region forms part of a long alpha-helix extending to Sth1 residue Leu-381 (Snf2 
residue Leu-659) (Figure 2.2).  While the residues comprising the minimal HSA 
domain are poorly conserved within the SWI/SNF family, extending the domain to 
the end of this predicted helix would include 22 additional amino acids, which are 
more highly conserved and represent part of the adjacent post-HSA (pHSA domain) 
(Figure 2.2). At this point, it is important to note that there is some ambiguity as to 
where the HSA domain ends and the adjacent pHSA domain begins.  Therefore, I 
used sequence conservation as a guide for determining a boundary between these 
two domains.  As a result, the HSA domain is taken to end at Sth1 residue Arg-369 
(Snf2 residue Arg-647) for the purposes of this dissertation. 
To test whether this highly conserved 22-aa segment of the pHSA domain is 
important for Arp7/9 binding, I designed two constructs, termed mHSA (for minimal 
HSA) and HSA-pHSA, which either included or lacked this region.  The mHSA 
constructs comprise Sth1 residues 301-364 and Snf2 residues 579-642, while the  
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Figure 2.2 – The pHSA is more highly conserved than the HSA domain. 
Domain architecture of Sth1 (catalytic subunit of the RSC complex) and definition 
of Sth1 and Snf2 (catalytic subunit of the SWI/SNF complex) constructs made for 
this study.  Also shown is a sequence alignment of the HSA-pHSA regions of 
yeast Sth1 (UniProt P32597), yeast Snf2 (UniProt P22082), Drosophila Brm 
(UniProt P25439), and human Brg1 (UniProt P51532).  A blue background 
highlights sequence conservation, with dark blue indicating highest conservation. 
Secondary structure prediction with the program Jpred3 (Cole et al., 2008) 
identifies two long helices within this region (indicated above). The helix of the 
HSA-pHSA region was confirmed by the crystal structure of the Rtt102-Arp7/9-
(HSA-pHSA) subcomplex of SWI/SNF. (Schubert et al., 2013). 
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HSA-pHSA constructs comprise Sth1 residues 301-387 and Snf2 residues 579-665 
(Figure 2.2).  To increase their solubility, these constructs were expressed with 
maltose-binding protein (MBP) fused at the N-terminus.  I used ITC to analyze the 
interaction of the Arp7/9 heterodimer with the mHSA and HSA-pHSA fragments of 
Sth1 and Snf2 (Figure 2.3A,B). ITC experiments for this study were repeated three 
times (the values given in the figures and the thermodynamic parameters listed in 
Table 2.1 correspond to the average of these three measurements).  To my surprise, 
I found that construct HSA-pHSA of Sth1 bound to Arp7/9 with ~25-fold higher 
affinity than construct mHSA (KD values 25 vs. 620 nM).  In fact, the difference in 
affinity for the equivalent constructs of Snf2 was even greater, ~130-fold (KD values 
6.4 vs. 820 nM).  This was a surprising finding in light of the recent crystal structure 
of the quaternary complex of Rtt102-Arp7/9 with a similar HSA-pHSA fragment of 
Snf2, in which the Arps do not appear to make direct contacts with the C-terminal 22 
amino acids of the alpha helix (herein referred to at the HSA-pHSA helix) (Schubert 
et al., 2013).  Finally, I also found that hetero-dimerization is required for binding of 
the Arps to the HSA-pHSA helix, since individually neither Arp7 nor Arp9 was able to 
interact with the HSA-pHSA region of Snf2 (Figure 2.3B).   
2.4 – Rtt102-Arp7/9 interacts solely with the HSA domain 
Arp7/9-containing remodelers also carry subunit Rtt102, which previous 
biochemical (Szerlong et al., 2008) and structural (Schubert et al., 2013) studies 
suggest interacts with the Arps, but not the HSA domain.  In light of my finding that 
the previously defined minimal HSA domain is not sufficient for full binding of Arp7/9,  
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Figure 2.3 – The HSA domain lacks the full Arp7/9 binding surface. 
A,B) Heats of injection and binding isotherms for the ITC titrations of the mHSA 
and HSA-pHSA constructs of Sth1 A) and Snf2 B) into Arp7/9. The average 
binding affinities and stoichiometries of the fits from three independent 
experiments are indicated (refer to Table 2.1 for the average thermodynamic 
parameters of the titrations). 
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Table 2.1 – Thermodynamic parameters of the fits of ITC titrations. 
 KD (µM) DH (kcal/mole) -TDS (kcal/mole) n 
Arp7     
  Snf2578-665 No binding 
Arp9     
  Snf2578-665 No binding 
Arp7/9     
  Sth1301-364 0.62 ± 0.03 -31.6 ± 0.2 23.1 ± 0.1 1.29 ± 0.22 
  Sth1301-387 0.025 ± 0.010 -51.6 ± 1.4 41.3 ± 1.5 0.86 ± 0.07 
  Snf2578-642 0.82 ± 0.16 -27.1 ± 0.6 18.9 ± 0.6 1.34 ± 0.14 
  Snf2578-665 0.0064 ± 0.0008 -45.9 ± 4.4 34.8 ± 4.4 1.09 ± 0.20 
Rtt102     
  Arp7 No binding 
  Arp9 0.78 -59.7 51.5 0.815 
  Arp7/9 0.0027 ± 0.0008 -67.0 ± 4.0 55.4 ± 4.1 1.09 ± 0.02 
Rtt102-Arp7/9     
  Sth1301-364 0.12 ± 0.02 -37.0 ± 4.8 27.5 ± 4.7 1.13 ± 0.11 
  Sth1301-387 0.045 ± 0.007 -55.3 ± 0.5 45.4 ± 0.6 0.93 ± 0.03 
  Sth1301-1097 0.075 ± 0.005 -39.4 ± 0.9 29.8 ± 0.9 0.78 ± 0.13 
  Sth1388-1097 No binding 
  Snf2578-642 0.022 ± 0.001 -25.5 ± 0.5 15.2 ± 0.5 1.09 ± 0.02 
  Snf2578-665 0.026 ± 0.011 -39.0 ± 3.7 28.8 ± 3.4 0.99 ± 0.07 
ATP     
  Arp7 Weak binding (data not fitted) 
  Arp9 Weak binding (data not fitted) 
  Arp7/9 4.27 ± 1.34 -8.7 ± 1.9 1.5 ± 2.1 1.8 ± 0.3 
  Arp7/9-Sth1301-387 0.83 ± 0.08 -6.9 ± 0.5 -1.2 ± 0.5 1.29 ± 0.09 
  Rtt102-Arp7/9 0.20 ± 0.08 -17.9 ± 1.6 -8.8 ± 1.7 0.70 ± 0.05 
  Rtt102-Arp7/9- 
  Sth1301-387 
0.094 ± 0.02 -12.9 ± 0.4 3.5 ± 0.4 0.59 ± 0.04 
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I probed whether binding of Rtt102 to the Arps may affect its interactions with the 
HSA-pHSA region.  To test this possibility, I first analyzed the interaction of the Arps 
with Rtt102 by native gel electrophoresis (Figure 2.4).  Alone, neither Rtt102 nor 
Arp7 entered the gel, which is not surprising, since Rtt102 is largely unstructured 
and Arp7 does have a tendency to aggregate in isolation.  On the other hand, Arp9 
and the Arp7/9 heterodimer entered the gel, but ran as two separate species. 
Because these proteins run as single bands by regular gel electrophoresis (Figure 
2.1A), the presence of multiple bands in the native gel is consistent with 
conformational heterogeneity or lack of stability.  In contrast, the ternary complex 
Rtt102-Arp7/9 ran as a single band in the native gel (Figure 2.4).  Since the hetero-
dimer ran as two bands and Rtt102 did not even enter the gel, this result suggests 
that the interaction of Rtt102 with the Arp7/9 heterodimer promotes a discrete and 
stable conformation of the Arps. 
Next, I analyzed the interaction of Rtt102 with the Arps using ITC (Figure 2.5).  
Rtt102 did not interact with Arp7 and bound Arp9 with relatively weak affinity (780 
nM).  In contrast, Rtt102 bound with high affinity to the Arp7/9 heterodimer (KD = 2.7 
nM).  Given this tight interaction, it is thus not surprising that the ternary complex of 
Rtt102-Arp7/9 migrates as a single species in the native gel.  The ITC data are also 
consistent with the crystal structure (Schubert et al., 2013) in which Rtt102 interacts 
mostly with Arp9, but also contacts Arp7, forming a bridge across the Arp7-Arp9 
interface. 
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Figure 2.4 – Rtt102 stabilizes the Arp7/9 heterodimer. 
Native PAGE analysis (6%, pH 8.8) of recombinant proteins and complexes (as 
indicated). 
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Figure 2.5 – Rtt102 binds Arp7/9 with high affinity. 
Heats of injection and binding isotherms for the ITC titrations of Rtt102 into Arp7 
(green), Arp9, and Arp7/9. 
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The effects of high affinity Rtt102 binding on the stability and conformation of 
Arp7/9 raise the possibility that the resulting ternary complex may interact with the 
catalytic subunit of SWI/SNF remodelers in a different manner than the hetero-dimer.  
More specifically, the pHSA domain, which appears to contribute to Arp7/9 binding, 
may be dispensable given the more compact conformation promoted by Rtt102.  To 
test this hypothesis, I analyzed the interaction of co-purified Rtt102-Arp7/9 with the 
same mHSA and HSA-pHSA constructs of Sth1 and Snf2 as described above 
(Figure 2.6A,B).  Strikingly, in comparison to the Arp7/9 heterodimer, Rtt102 
enhanced the affinity of Arp7/9 for the mHSA construct of Sth1 5-fold (KD values 120 
vs. 620 nM) and 37-fold for that of Snf2 (KD values 22 vs. 820 nM).  To confirm that 
these results were indicative of a more restricted binding surface on Sth1 and Snf2, 
the titrations were performed against the HSA-pHSA constructs.  In stark contrast to 
what was observed in the absence of Rtt102 (Figure 2.3A,B), the ternary complex 
Rtt102-Arp7/9 bound to the HSA-pHSA construct of Sth1 with only ~2.7-fold greater 
affinity than to the mHSA construct (KD values 45 vs. 120 nM), and with nearly 
identical affinities to the HSA-pHSA and mHSA regions of Shf2 (KD values 26 vs. 22 
nM).  It thus appears that the 22-aa C-terminal portion of the HSA-pHSA helix, which 
adds dramatically to the affinity of the Arp7/9 heterodimer, contributes little to the 
interaction when Rtt102 is bound to the Arps (Figure 2.6A,B and Table 2.1).  
The binding studies describe above suggest that in the absence of Rtt102, 
Arp7/9 adopts a more ‘relaxed’ or extended conformation, making contacts with the 
whole HSA domain and part of the adjacent pHSA domain (Figure 2.7).  In turn, the 
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Figure 2.6 – The HSA domain is sufficient for full binding of Rtt102-Arp7/9. 
A,B) ITC titrations of the mHSA and HSA-pHSA constructs of Sth1 A) and Snf2 B) 
into Rtt102-Arp7/9.  The average binding affinities and stoichiometries of the fits 
from three independent experiments are indicated. 
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Figure 2.7 – Rtt102 stabilizes a compact conformation of Arp7/9. 
A schematic diagram depicting the conformational change in Arp7/9 promoted by 
Rtt102 binding.  Here, Arp7/9 binding is restricted to the HSA domain, whereas in 
the absence of Rtt102, the adjacent pHSA domain contributes to the interaction 
with the Arps. 
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binding of Rtt102 stabilizes a more compact conformation of the Arps, in which they 
interact mostly with the HSA domain, as observed in the crystal structure (Schubert 
et al., 2013).  Since the pHSA residues are highly conserved, in the absence of 
Rtt102, they are likely to serve an important function distinct from Arp binding, which 
will be interrogated in the next chapter. 
2.5 – The binding site for Rtt102-Arp7/9 is fully contained within the HSA 
domain of the ATPase 
Even though Rtt102-Arp7/9 binds to the minimal HSA constructs of Sth1 and 
Snf2 with high affinity, it is unknown whether this poorly conserved region accounts 
for all the interactions linking Rtt102-Arp7/9 to SWI/SNF remodelers, as concluded 
by a previous study using pull-down experiments from yeast extracts and co-
purification of co-expressed proteins (Szerlong et al., 2008).  One important 
observation of this study was that the catalytic subunits of actin/Arp-containing 
remodelers also share two additional highly conserved regions, the pHSA domain 
and protrusion-1 (P1).  The pHSA domain is a ~40-aa region found in between the 
HSA and the first recA domain, is unique to actin/Arp-containing remodelers, and is 
highly conserved within the SWI/SNF and INO80 families.  P1 is a ~50-aa insertion 
within the N-terminal recA domain consisting of three alpha helices (Figure 2.2).  
While P1 is not unique to actin/Arp remodelers, it is, like the pHSA region, highly 
conserved within the the SWI/SNF and INO80 remodeler families. 
Notably, dual deletion of Arp7/9 in yeast is lethal, but mutations in the pHSA 
or P1 regions of Sth1 suppress lethality (Szerlong et al., 2008), raising the possibility 
that the Arps could interact with these two regions.  It should be noted that even 
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when expressed as an MBP fusion to improve solubility and stability, Sth1 construct 
301-423, comprising the full pHSA domain, elutes from amylose resin heavily 
degraded.  Therefore, I could not directly assess the role of the full pHSA region in 
Rtt102-Arp7/9 binding.  Instead, I measured binding of Rtt102-Arp7/9 to two Sth1 
constructs, extending from either residue Val-301 or Ala-388 to the end of the SnAC 
domain, respectively (Figure 2.2).  Rtt102-Arp7/9 bound to Sth1 construct 301-1097 
with a KD of 75 nM, i.e. with similar affinity and thermodynamic parameters as for the 
isolated minimal HSA construct (KD = 45 nM), but did not bind to construct 388-1097 
that lacks the HSA-pHSA helix (Figure 2.8A,B).  These results suggest that the 
ATPase domain, and specifically the conserved pHSA and P1 regions, do not 
directly contribute to the affinity of Sth1 for Rtt102-Arp7/9. 
2.6 – Interaction with Rtt102 and the HSA domain increases the affinity of 
Arp7/9 for ATP  
Cytoskeletal actin and Arps bind and hydrolyze ATP, which regulates their 
transition in and out of filamentous networks (Dominguez and Holmes, 2011; Pollard 
and Cooper, 2009).  Because nuclear Arps share the actin fold, and the nucleotide-
binding pocket is particularly well conserved, they could be expected to also bind 
and hydrolyze ATP.  Indeed, Arp4 and Arp8 have been shown to co-purify with ATP, 
although like actin (Dominguez and Holmes, 2011; Pollard and Cooper, 2009), they 
had little detectable ATPase activity in isolation (Fenn et al., 2011; Gerhold et al., 
2012; Pollard and Cooper, 2009; Saravanan et al., 2012).  Surprisingly, however, 
genetic data shows that mutating the nucleotide-binding pocket of Arp7 or Arp9 has 
no effect on yeast survival, which led to the suggestion that they do not bind ATP  
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Figure 2.8 – The HSA domain accounts for all Rtt102-Arp7/9 interactions. 
A) Titration of Rtt102-Arp7/9 into the 301-1097 and 388-1097 (green) fragments of 
Sth1. The average binding affinities and stoichiometries of the fits from three 
independent experiments are indicated.  B) Thermodynamic parameters of the 
interactions of Rtt102-Arp7/9 with 301-364 (HSA), 301-387 (HSA-pHSA), and 301-
1097 fragments of Sth1. Error bars represent the standard deviations from three 
independent experiments. Refer to Table 2.1 for further details. 
 
  
 49 
(Cairns et al., 1998).  The structure of Rtt102-Arp7/9-Snf2(HSA-pHSA) was also 
determined in the absence of nucleotide (Schubert et al., 2013).  While these results 
could be interpreted as evidence that Arp7/9 does not bind ATP, this has not been 
formally investigated. 
Here, I quantitatively analyzed the binding of ATP to Arp7, Arp9, and their 
heterodimer in the presence and absence of Rtt102.  Individually, Arp7 and Arp9 
appeared to interact with ATP, albeit very weakly (Figure 2.9A).  The titration of a 
~70-fold molar excess of ATP produced a more pronounced isotherm for Arp7 than 
for Arp9 (estimated KD values of 12 µM and 44 µM, respectively), indicating that 
ATP has a slight preference for isolated Arp7.  Because these affinities appeared too 
low for this family of proteins (Saravanan et al., 2012), I decided to test whether the 
affinity for nucleotide increased when Arp7 and 9 come together in a stable 
heterodimer.  However, ATP also bound with relatively weak affinity to Arp7/9 (KD = 
4.3 µM), and the stoichiometry converged to ~1.8, possibly reflecting the presence of 
two weak binding sites within the heterodimer (Figure 2.9B).  Remarkably, when we 
titrated ATP into Rtt102-Arp7/9 the affinity increased > 20-fold (KD = 200 nM), which 
together with other data presented here suggests a stabilizing effect of Rtt102 on 
Arp7/9 (Figure 2.9C).  In this case, the stoichiometry of the interaction converged to 
0.7, indicating that nucleotide binds to a single site within the Rtt102-Arp7/9 
complex.  Because individually Arp7 displayed higher affinity for ATP than Arp9 
(Figure 2.9A), it is possible that this site resides within Arp7.  This is also consistent 
with the crystal structure of Rtt102-Arp7/9 in complex with the HSA-pHSA helix of 
Snf2 (Schubert et al., 2013), in which the ATP-binding cleft of Arp7 displays a  
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Figure 2.9 – Rtt102 promotes tight ATP binding a single site in Arp7/9. 
A-C) ITC titrations of ATP into (A) Arp7 (red) and Arp9 (blue), (B) Arp7/9 and (C) 
Rtt102-Arp7/9. The binding affinities and stoichiometries of the fits are indicated 
(refer to Table 2 for further details).  D) Exchange of e-ATP bound to Rtt102-Arp7/9 
by addition of ATP (orange) or ADP (green).  Data were buffer-subtracted and 
normalized as described in Chapter 5 
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relatively closed conformation resembling that of actin, whereas Arp9 displays a 
wide-open cleft. 
As an alternative method to explore the binding of ATP to Rtt102-Arp7/9, I 
monitored the exchange of e-ATP, an ATP analog whose fluorescence increases 
when bound to protein (Wang and Taylor, 1981).  In these experiments, e-ATP pre-
bound to Rtt102-Arp7/9 was competed out with ATP (or ADP), which produces a 
fluorescence decrease.  The addition of a 12-fold molar excess of ATP led to a sharp 
decrease in fluorescence, while ADP was 5-fold less efficient at displacing e-ATP 
(Figure 2.9D).  This confirms that Rtt102-Arp7/9 binds nucleotide, with a clear 
preference for ATP vs. ADP. 
In light of these results, I also tested whether the HSA domain altered the 
affinity of the Arps for nucleotide. Indeed, like Rtt102, the HSA-pHSA helix also 
promoted tighter binding of ATP to the Arps (Figure 2.10A), albeit to a lesser extent 
than Rtt102 (KD values 827 vs. 200 nM).  Interestingly, the tightest binding of ATP 
(KD = 94 nM) was observed for the quaternary complex Rtt102-Arp7/9-Sth1(HSA-
pHSA) (Figure 2.10B,C) and, as above, nucleotide appeared to bind to a single site 
in this complex.  This suggests that Arp7/9 is most stable when bound to both Rtt102 
and the Sth1 catalytic subunit. 
2.7 – The structure of Rtt102-Arp7/9 shows ATP-binding site to Arp7 
 Given the role of Rtt102 in stabilizing a conformation of Arp7/9 that interacts 
strongly with the HSA domain and nucleotide, the functionally relevant Arp module in 
budding yeast SWI/SNF-family remodelers is likely to be the ATP-bound ternary  
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Figure 2.10 – Sth1 promotes tight ATP binding a single site in Arp7/9. 
A,B) ITC titrations of ATP into A) Arp7/9-(HSA-pHSA) and (G) Rtt102-Arp7/9-
(HSA-pHSA).  The average binding affinities and stoichiometries of the fits are 
indicated (see also Table 2.1). (C) Diagram illustrating the incremental increase in 
nucleotide-binding affinity upon assembly of the quaternary complex of Rtt102-
Arp7/9-(HSA-pHSA) (color-coded).  
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complex of Rtt102-Arp7/9.  Therefore, it is important to better understand this ternary 
complex, in particular the binding site and role of ATP.  During the course of this 
study, the crystal structures of Arp7/9, both in isolation (PDB accession code 3WEE) 
and in complex with Rtt102 and the HSA-pHSA helix of Snf2 (PDB accession code 
4I6M), were reported (Lobsiger et al., 2014; Schubert et al., 2013).  Interestingly, 
neither structure contains ATP bound, presumably because these complexes were 
crystallized in the presence of molar concentrations of phosphate and sulfate ions, 
which occupy the nucleotide-binding pockets of both Arps in each structure.  Indeed, 
the authors noted that soaking crystals of the quaternary complex with high 
concentrations of ATP did not result in nucleotide binding (Schubert et al., 2013).  In 
light of these efforts and the importance of fully understanding the Rtt102-Arp7/9 
regulatory module, I set out to determine the crystal structure of the nucleotide-
bound ternary complex.   
To avoid a similar scenario in which the precipitants driving crystallization 
saturate the ATP binding site within Arp7/9, I pre-incubated Rtt102-Arp7/9 with ATP 
prior to crystallization screens.  Using this strategy, I obtained initial crystals with a 
different chemical, polyethylene glycol 3350, as the main precipitant (Figure 2.11A). 
Subsequent rounds of seeding and optimization resulted in larger crystals more 
suitable for harvesting and data collection (Figure 2.11B).  The crystals, which 
diffracted to a relatively low resolution (3.25 Å) (Figure 2.11C and Table 2.2), contain 
two copies of the Rtt102-Arp7/9 ternary complex in the P1 unit cell (RMSD=0.51 Å 
for 833 equivalent Ca atoms) (Figure 2.12A and Table 2.2).  The overall structure, 
and specifically the disposition of the Arps relative to each other, is marginally closer  
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Figure 2.11 – Crystallization and diffraction of ATP-bound Rtt102-Arp7/9. 
A) Initial, needle-like crystals of Rtt102-Arp7/9 bound to ATP obtained using the 
sitting drop method.  B) Larger, plate-like crystals obtained using the hanging drop 
method, with the initial crystals used as seeds to nucleate crystal growth.  C) 
Diffraction pattern of the crystals from B).  The outer-most resolution ring is 3.25 Å 
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Figure 2.12 – Arp7 binds but does not hydrolyze ATP within Rtt102-Arp7/9. 
A) Crystal structure of the ATP-bound ternary complex of Rtt102-Arp7/9.  B) Wall-
eyed stereo view of the ATP-binding pocket of Arp7.  Also shown is a composite 
2Fo-Fc omit map (blue mesh) contoured at 1.1s.  C) ATPase activities of Arp7, 
Rtt102-Arp7/9, and Rtt102-Arp7/9-Sth1301-1097 (±DNA).  Error bars represent the 
standard deviations from three independent experiments.  D) Comparison of 
residues in the ATP-binding clefts of actin and Arp7. 
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Table 2.2 – Crystallographic data and refinement statistics 
Data collection   
Space group P 1 
Cell dimensions   
a, b, c (Å) 
a, b, g (°) 
79.45, 88.03, 105.49 
109.02, 104.65, 96.20 
Wavelength (Å) 1.5418 
Resolution (Å) 40.0 – 3.25 (3.42 – 3.25) a 
Rmerge (%) 9.7 (41.8) 
I / σI 11.2 (2.4) 
No. unique reflections 40,398 (5,312) 
Completeness (%) 96.6 (92.0) 
Redundancy 3.4 (2.7) 
Wilson B-factor (Å2) 60.61 
Refinement   
Resolution (Å) 39.37 – 3.25 (3.36 – 3.25) 
No. reflections 38,745  
Rwork (%) / Rfree (%) 27.4 / 31.9 
No. atoms  
Protein 
Ligand (ATP, SO4-) 
14,131 
77 
RMS deviations  
Bond lengths (Å) 
Bond angles () 
0.004 
1.020 
B-factors (Å2)  
Protein 
Ligand 
70.7 
72.1 
Ramachandran (%) 
Favored 
Outliers 
 
97.0 
0.12 
PDB code 5TGC 
a Values in parentheses are for highest-resolution shell 
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to that of the quaternary complex Rtt102-Arp7/9-Snf2HSA-pHSA (RMSD of 0.64 Å for 
774 equivalent Ca atoms) than that of the Arp7/9 heterotrimer (RMSD of 0.67 Å for 
758 equivalent Ca atoms).  The conformation of Rtt102 is also very similar to that 
observed in the complex of Rtt102-Arp7/9-Snf2HSA-pHSA, and although the current 
structure reveals 13 more amino acids for this subunit, a large portion of Rtt102 (90 
out the 157 amino acids) remains unresolved.  The observable portion of Rtt102 
interacts mostly with Arp9, and seems to act as a ‘clip’ holding the Arps together, 
which may explain why Rtt102 enhances the affinity of Arp7/9 for both Sth1 and 
nucleotide.  Finally, unlike previous structures, the current structure clearly shows 
the presence of ATP in the nucleotide-binding cleft of Arp7 but not Arp9 in composite 
omit maps, for both complexes of the unit cell (Figure 2.12B). 
Since actin in isolation is an extremely poor ATPase, it is not surprising that I 
found that Arp7 lacks ATPase activity, either alone or within the ternary complex 
Rtt102-Arp7/9, whereas the quaternary complex Rtt102-Arp7/9-Sth1301-1097 displays 
strong DNA-dependent ATPase activity (Figure 2.12C).  The structure offers several 
clues that might explain the lack of ATPase activity of Arp7.  Out of 26 residues that 
either directly interact with or fall near the nucleotide, and may thus coordinate water 
molecules that interact with the nucleotide, only 9 are conserved between actin and 
Arp7 (Figure 2.12D).  In particular, the all-important actin residue Lys-18, which 
anchors the nucleotide in place by interacting with both the a- and b-phosphates, 
becomes Val-18 in Arp7, which cannot support these interactions.  In actin, the b- 
and g-phosphates of the nucleotide are additionally coordinated by a divalent cation 
(Mg2+ under physiological conditions, or Ca+2 in most of the structures).  In contrast, 
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there is no cation associated with the nucleotide in the structure of Arp7.  Indeed, 
Arp7 appears to lack a cation-binding site, as two residues that coordinate water 
molecules that hold the cation in place in actin, Asp-11 and Gln-137, have changed 
in Arp7 to His-11 and Glu-141, respectively.  Specifically, Gln-137 and the cation 
coordinate a water molecule thought to serve as the nucleophile in the ATP 
hydrolysis reaction of actin.  Strikingly, mutating this residue to glutamic acid in yeast 
actin (the amino acid found in Arp7) results in lack of viability of budding yeast 
(Vorobiev et al., 2003).  The same study found that residue His-161 in the actin cleft 
is also absolutely required for yeast viability.  In Arp7, His-161 becomes Asn-165. 
Therefore, the lack of ATPase activity in Arp7 is supported by the structure and 
previous studies on actin. 
2.7 – Discussion 
Chromatin remodelers are large complexes, containing up to 17 protein 
subunits organized around the central ATPase subunit.  The role of many of these 
subunits remains unknown, but it is becoming increasingly clear that they participate 
in modulation of the catalytic activity of the ATPase and targeting of remodelers to 
nucleosomes, as reviewed in section 1.2 of this dissertation.  Subunits Arp7, Arp9 
and Rtt102 of SWI/SNF-family remodelers co-purify and assemble into a sub-
complex that is recruited to the catalytic subunit by interaction with the HSA domain 
(Schubert et al., 2013; Szerlong et al., 2008).  Interestingly, the Arp7/9 heterodimer 
can form and can bind to the HSA domain of the ATPase in the absence of Rtt102 
(Szerlong et al., 2008).  What is more, the remodeling activity of an Arp7/9-Sth1 
subcomplex of RSC is ~2.4-fold higher in the absence than in the presence of Rtt102 
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(Schubert et al., 2013).  These findings suggest that, like other remodeler subunits, 
Rtt102 might also play a regulatory role. 
Consistent with this idea, this work documents profound effects of Rtt102 on 
the structure of the Arp7/9 heterodimer. Thus, my biochemical and structural data 
show that Rtt102 is required for tight ATP binding by Arp7.  Furthermore, Rtt102 
restricts Arp7/9 binding to the HSA domain.  In this light, it is peculiar that the crystal 
structures of Arp7/9, both in isolation (Lobsiger et al., 2014) and as part of a 
quaternary complex with Rtt102 and the HSA-pHSA helix of Snf2 (Schubert et al., 
2013), reported during the course of my dissertation work, do not reveal large 
conformational changes in Arp7/9 that would be expected given the binding data 
presented here.  However, as strongly suggested by native gel analysis (Figure 2.4), 
Arp7/9 is conformationally heterogeneous.  As such, even in isolation, it is likely to 
be able to adopt the conformation otherwise stabilized by Rtt102, which may indeed 
constitute the preferred disposition of the Arps relative to each other in the 
crystallization environment.   
In light of the dramatic effects that Rtt102 binding exerts on the Arps, it is 
important to consider whether Rtt102 is constitutively bound to Arp7/9, or if the 
interaction can be regulated throughout the remodeling cycle.  Given the high affinity 
of Rtt102 for the Arp7/9 hetero-dimer, and the fact that the three proteins pull-down 
together with the HSA domain (Szerlong et al., 2008), it is tempting to assume that 
the interaction is indeed constitutive.  However, given the dynamic association of 
remodelers with nucleosomal components throughout the remodeling process, the 
possibility that Rtt102 may dissociate from the Arps in a regulated manner cannot be 
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excluded.  Furthermore, it is curious that Rtt102 residue Ser-77 has been detected 
as a phosphorylation target for the Cdk1 kinase, which is critical for cell cycle 
regulation (Holt et al., 2009).   Therefore, analogous to the way in which post-
translational modifications of histones can affect their association with remodeler 
subunits, it is possible that phosphorylation of Rtt102 could affect its association with 
Arp7/9.  Interestingly, this residue is part of an unstructured stretch of Rtt102 that 
interacts with subdomain 2 of Arp9 and which is resolved in the crystal structure 
presented here.  As such, it will be interesting to determine whether phosphorylation 
of Ser-77 indeed plays a regulatory role. 
Curiously, in both the ATP-bound crystal structure of Rtt102-Arp7/9 presented 
here and that of the quaternary complex (Schubert et al., 2013), the C-terminal 70 aa 
are not resolved, even though full-length Rtt102 was used in the crystallization 
sample in both cases.  Therefore, the effects of Rtt102 on the Arp7/9 heterodimer 
described here are taken to be entirely due to the function of its N-terminal 90 amino 
acids.  What, then, is the role of the unresolved C-terminus?  One intriguing 
possibility is that this region, while disordered in the context of the Arps and the HSA 
domain, confers an additional regulatory element to Rtt102 by mediating interactions 
with nucleosomes and/or additional auxiliary subunits.  Indeed, the case for a 
nucleosome-interacting role is supported by cross-linking experiments which have 
suggested that Rtt102 may directly interact with histone H2A (Sen et al., 2013).  
Conversely, the sub-complex of Rtt102-Arp7/9-Snf2HSA-pHSA only binds nucleosomes 
with free linker DNA (Schubert et al., 2013).  Thus, any Rtt102-nucleosome 
interactions could be of weak affinity, or may only occur in the context of the full RSC 
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and/or SWI/SNF complexes.  Nevertheless, the possibility that Rtt102, in addition to 
stabilizing the Arps, may function by interacting with histones merits investigation, 
particularly since Arp7/9 in isolation does not bind nucleosomes, a stark contrast to 
the importance of the nucleosome-interacting actin/Arp4/Arp8 module in the 
regulation of INO80 remodelers. 
Finally, the biochemical and structural data presented here reveal the 
presence of an actin-like nucleotide binding site in Arp7.  However, I also established 
that Rtt102-Arp7/9 lacks discernable ATPase activity (Figure 2.12C), suggesting that 
ATP binding to Arp7 is unlikely to play a regulatory role.  And yet, ATP is likely 
bound under physiological conditions, since the concentration of ATP in the nucleus 
is ~3.5 mM (Traut, 1994) and Rtt102-Arp7/9 binds ATP with KD = 200 nM, and even 
higher affinity when bound to the HSA domain.  What, then, is the role of ATP 
binding to Arp7? 
Comparison with a recent structure of actin/Arp4 bound to the HSA domain of 
Swr1 (Cao et al., 2016) offers a potential explanation.  In this structure, Arp4 
occupies the position of Arp7, at the N-terminal end of the HSA domain, whereas 
actin takes the position of Arp9.  Remarkably, Arp4 displays a closed-cleft 
conformation and contains ATP bound, whereas actin shows an open cleft 
conformation and lacks nucleotide (just like Arp9 in my structure).  There are over a 
hundred actin entries in the Protein Data Bank, and to my knowledge this is the first 
actin structure that has no nucleotide bound.  In contrast, Arp7, which in isolation 
has low affinity for ATP (KD = 12 µM), binds nucleotide tightly as part of the 
quaternary complex Rtt102-Arp7/9-Sth1301-387.  Thus, there appears to be a 
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conserved structural requirement for a closed, nucleotide-bound cleft for the subunit 
associated with the N-terminal half of the HSA domain and an open, nucleotide-free 
cleft for the subunit bound next to the pHSA domain.  In other words, I propose that 
the role of nucleotide binding to actin/Arp-containing remodelers is not regulatory, 
but structural.  If this prediction is correct, it could be expected that the fission yeast 
remodelers RSC and SWI/SNF, which contain Arp9 and the Arp4 homolog Arp42 
(instead of Arp7) (Monahan et al., 2008), will have nucleotide-bound Arp42 and 
nucleotide-free Arp9 at the N- and C-terminal ends of the HSA domain, respectively. 
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CHAPTER 3: Arp7/9 regulates intramolecular interactions and 
DNA binding to the catalytic subunit of the RSC chromatin 
remodeler in an Rtt102-dependent manner 
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3.1 – Overview 
Chromatin-remodeling complexes are assembled around their catalytic 
subunits, which feature a central ATPase domain and flanking sequences that recruit 
auxiliary subunits.  The catalytic subunits of two remodeler families, SWI/SNF and 
INO80, bind actin and actin-related proteins (Arps) through a helicase/SANT-
associated (HSA) domain.  Sth1, the catalytic subunit of the yeast SWI/SNF-family 
remodeler RSC, recruits the Arp7/9 heterodimer, which comes tightly associated 
with another auxiliary subunit, Rtt102.  Rtt102-Arp7/9 regulates the activity of RSC, 
but the underlying structural mechanisms are poorly understood.  Structural analysis 
by small angle x-ray scattering reveals that when bound to Rtt102, the complex of 
Arp7/9 with the ATPase domain of Sth1 assumes a more stable, compact 
conformation.  To further probe the specific effects of the Arps and Rtt102 on the 
structure and function of the ATPase domain, I designed a novel biochemical assay 
to test for intramolecular interactions that may regulate the Sth1 ATPase.  Between 
the HSA and ATPase domains, actin/Arp-containing remodelers present a highly 
conserved ~60-aa sequence known as the post-HSA (pHSA) domain.  I show that 
the pHSA domain interacts directly with the ATPase domain, specifically contacting 
another highly conserved region known as protrusion-1.  Binding of Arp7/9 to the 
HSA domain weakens this interaction in an Rtt102-dependent manner, resulting in 
reduced affinity of the ATPase for DNA.  Together, the biochemical and structural 
data suggest that Rtt102 stabilizes a conformation of Arp7/9 that potentiates binding 
to the HSA domain and is able to release regulatory intramolecular interactions 
between the pHSA and ATPase domains.  The results suggest a molecular 
mechanism for how actin and Arps may regulate their host remodelers. 
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3.2 – Binding of Rtt102 stabilizes the Arp7/9-Sth1 subcomplex of RSC 
 In the previous chapter, I presented a detailed biochemical and structural 
analysis of the intra-molecular interactions within a subcomplex of RSC, consisting 
of Arp7/9 bound to an Sth1 construct that extends from the HSA domain to include 
the catalytic ATPase domain.  This study established Rtt102 as a stabilizing factor 
for Arp7/9.  Given its effect on the conformation of Arp7/9 and the resulting changes 
in how the Arps interact with the HSA domain of Sth1, I asked whether Rtt102 
binding also has an effect on the stability conformation of this RSC subcomplex. 
To test this possibility, I used small angle x-ray scattering (SAXS) to examine 
the overall conformation and stability of Arp7/9-Sth1301-1097, in the presence and the 
absence of Rtt102.  As a reference, I also analyzed the quaternary complex of 
Rtt102-Arp7/9-Sth1301-387, containing just the HSA-pHSA helix.  Scattering data 
collected at several concentrations of the three RSC sub-complexes showed a linear 
dependence of the scattering intensity with protein concentration, which is indicative 
of a high sample quality and lack of aggregation (Figure 3.1A-C).  To confirm that the 
samples were indeed mono-dispersed and non-aggregated, I calculated Guinier 
plots for all sub-complexes.  The Guinier plot focuses on the scattering profile at very 
small angles, and a linear plot is a hallmark of mono-dispersed, non-aggregated 
sample (Blanchet and Svergun, 2013).  Here, Guinier analysis revealed linear plots 
for the two complexes containing Rtt102, consistent with mono-dispersed species, 
whereas that of Arp7/9-Sth1301-1097 was slightly non-linear, which probably reflects 
weak aggregation in the sample (Figure 3.1D).  This suggests that Rtt102, in  
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Figure 3.1 – SAXS analysis of actin-related subcomplexes of RSC. 
A-C) X-ray scattering data collected at three different concentrations from the RSC 
sub-complexes: A) Rtt102-Arp7/9-Sth1301-387, B) Rtt102-Arp7/9- Sth1301-1097, and C) 
Arp7/9- Sth1301-1097.  Scattering intensities are plotted vs. momentum transfer, and 
the dependence of I(0) on sample concentration is shown in insets.  D) Guinier 
plots of the three complexes calculated from the scattering data at the highest 
sample concentration (color-coded).  Data within the Guinier region (qRg <1.3) for 
the two Rtt102-containing complexes were linearly fitted (black lines).   
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addition to stabilizing the Arp7/9 hetero-dimer, also stabilizes the overall complex of 
the Arps with the catalytic subunit of the RSC remodeler. 
 To further probe the effects of Rtt102 on the conformation of the complex of 
Arp7/9 with the Sth1 ATPase domain, I calculated pair distance distribution 
functions, P(r), of the three RSC sub-complexes described above.  The P(r) function 
provides a direct measure of the mass distribution within the complexes (Putnam et 
al., 2007).  Indeed, these provided a further indication of the role of Rtt102 in 
promoting a stable sub-complex of RSC.  In the absence of Rtt102, the P(r) function 
of Arp7/9-Sth1301-1097 reaches a maximum at ~55 Å and decreases gradually to a 
maximum distance, Dmax, of ~285 Å (Figure 3.2A).  While this behavior might be 
indicative of an extended conformation, the non-linearity of the Guinier plot for this 
complex precludes an accurate analysis of particle dimensions.  Conversely, in the 
presence of Rtt102, the P(r) function shows a maximum at ~70 Å and Dmax of ~185 
Å, giving rise to a more bell-shaped function that is indicative of a more globular and 
compact complex. 
Consistent with the observation that Rtt102 stabilizes the Arp7/9-Sth1 
subcomplex of RSC, the Kratky plots of complexes containing Rtt102 were bell-
shaped, as expected for properly folded complexes, but that of Arp7/9-Sth1301-1097 
had a less globular profile (Figure 3.2B).  In keeping with its stabilizing effect, the 
presence of Rtt102 reduces the radius of gyration, Rg (a measure of the mass 
distribution around the center of mass (Putnam et al., 2007)) of Arp7/9-Sth1301-1097 
from 86.0 Å to 61.5 Å (Figure 3.2A).  While this difference could be due in part to 
weak aggregation of the Arp7/9- Sth1301-1097 complex, it appears reasonable to  
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Figure 3.2 – Rtt102 binding stabilizes the Arp7/9-Sth1 subcomplex of RSC 
A) Calculated P(r) functions of the three complexes analyzed by SAXS (color-
coded).  Dashed lines indicate the calculated Rg values for each complex.  B) 
Kratky plots of the three complexes (color-coded). 
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conclude that Rtt102 stabilizes this complex, and may also induce a conformational 
change, consistent with the binding of Rtt10-Arp7/9 being restricted to the HSA 
domain, which is not sufficient for full interaction with the Arp7/9 hetero-dimer.  
The P(r) function for the highly globular complex of Rtt102-Arp7/9-Sth1301-387 
had a symmetric appearance with maximum at ~60 Å, Dmax of ~130 Å, and an Rg of 
46.9 Å (Figure 3.2A).  Curiously this radius of gyration is larger than that calculated 
(Svergun et al., 1995) from the coordinates of the homologous crystal structure of 
Rtt102-Arp7/9 in complex with the HSA-pHSA helix of Snf2 (Schubert et al., 2013), 
32.3 Å, which is likely due to the absence of several disordered regions in the 
structure.  Thus, the complex analyzed by SAXS contains 270 residues more than 
revealed by the crystal structure, including 103 residues of Rtt102 and several loops 
of the Arps that were disordered in the structure. 
Using the data collected at the highest sample concentration (~10 mg/mL), 
which produces stronger scattering, I finally calculated low-resolution envelopes of 
the two Rtt102-containing complexes by averaging 20 ab initio structures (Figure 
3.3A).  The envelope of Rtt102-Arp7/9-Sth1301-387 could only be superimposed onto 
one side of that of Rtt102-Arp7/9-Sth1301-1097.  The large portion of the Rtt102-
Arp7/9-Sth1301-1097 envelope unaccounted for by this superimposition is predicted to 
belong to the recA domains (Figure 3.3B).  The size and shape of the envelopes is 
generally consistent with information available about the structures of the individual 
components, i.e. the crystal structures of Rtt102-Arp7/9-Snf2HSA-pHSA (Schubert et al., 
2013) and the related ATPase domain of Rad54 (Durr et al., 2005).  A definitive fit of 
these structures into the envelopes is not proposed because of ambiguities  
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Figure 3.3 – Low resolution envelopes of RSC subcomplexes. 
A) Comparison of the envelopes of Rtt102-Arp7/9-Sth1301-387 (blue) and Rtt102-
Arp7/9-Sth1301-1097 (red) resulting from averaging of 20 ab initio models. The 
average normalized spatial discrepancy (NSD) of the ab initio models are 1.06 ± 
0.06 and 0.99 ± 0.07 for the complexes of Rtt102-Arp7/9-Sth1301-387 and Rtt102-
Arp7/9- Sth1301-1097, respectively.  B) Superimposition of the envelopes and 
comparison with the most closely related crystal structures (shown to scale) 
available for the individual components, i.e. Rtt102-Arp7/9-Snf2(HSA-pHSA) (PDB 
code 4I6M) and the Rad54 ATPase domain (PDB code 1Z6A). 
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about the overall orientation of the domains, and the fact that the structures do not 
account for large segments of the proteins in the envelopes.  As stated above, in the 
absence of Rtt102, the ternary complex of Arp7/9-Sth1301-1097 is weakly aggregated 
and heterogeneous, thus a reliable ab initio envelope of this complex could not be 
calculated (Putnam et al., 2007). 
3.3 – The pHSA and ATPase domains of Sth1 interact with each other 
Having established that Rtt102 is required for the formation of a stable 
complex between the Arps and the Sth1 catalytic subunit, I then decided to 
investigate the structural mechanism through which the Rtt102-Arp7/9 module 
regulates the ATPase domain.  It is important to recall that in Sth1, mutations that 
restore viability of DArp7/9 yeast strains localize to two domains highly conserved 
within the SWI/SNF family: protrusion-1 (P1) within the ATPase domain and the ~60-
aa pHSA domain intervening between the HSA and ATPase domains (Szerlong et 
al., 2008) (Figure 3.4).  In the previous chapter, I ruled out the possibility that these 
two domains make direct contacts with Rtt102-Arp7/9.  Thus, a likely possibility is 
that the pHSA domain of Sth1 interacts with the ATPase domain, and this interaction 
could in principle be regulated by Rtt102-Arp7/9 binding to the neighboring HSA 
domain.  This hypothesis is strengthened by the fact that the HSA domain and the 
more highly conserved pHSA domain are unique to actin/Arp-containing remodelers.  
Furthermore, construct Sth1425-1097, lacking both the HSA and pHSA domains, is 
insoluble, even when expressed as an MBP fusion to promote solubility, whereas 
construct Sth1365-1097, lacking only the HSA domain, is soluble.  Finally, Sth1 
construct 301-423, comprising the full pHSA domain, is heavily degraded.   
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Figure 3.4 – SWI/SNF pHSA and P1 domains are highly conserved. 
Domain architecture of Sth1.  Shown below is a plot of sequence conservation scores 
calculated from nine representative sequences of catalytic subunits from SWI/SNF-
family remodelers and plotted on the 301-470 region of Sth1.  The binding sites of 
Arp7 and Arp9 and the engineered TEV site are indicated.  Also shown is a sequence 
alignment of the P1 region for the catalytic subunits of nine SWI/SNF-family 
remodelers (upper group) and three remodelers that do not bind actin or Arps (lower 
group).  The swapped regions of Sth1 and Rad54 are underlined (orange), and the 
resulting P1-swapped construct is shown at the bottom.  In both diagrams, red 
asterisks designate the sites of Sth1 mutations that restore viability of DArp7/9 strains. 
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Therefore, the instability of the isolated pHSA domain and its importance for the 
solubility of the ATPase domain suggested that these two domains might interact 
with each other. 
 To test this hypothesis, I designed a cleavable construct where the HSA-
pHSA and ATPase domains could be separated after expression and purification.  A 
canonical TEV protease cleavage site was engineered, with minimal changes to the 
endogenous sequence, within the poorly conserved linker between the two domains 
(Figures 3.4, 3.5).  The resulting construct (TEV-cleavable Sth1301-1097) contains a 
non-cleavable N-terminal His-tag for affinity purification and pull-down assays 
(Figure 3.5), such that the N-terminal HSA-pHSA fragment will retain the ability to 
bind nickel resin after TEV cleavage.  Strikingly, the purified protein remained 
soluble after cleavage with TEV protease, which was the first indication that the 
ATPase and N-terminal His-HSA-pHSA fragments remain bound to each other after 
cleavage.  Analysis by SDS-PAGE confirmed the formation of two fragments, with 
masses corresponding to the His-HSA-pHSA and ATPase domains (Figure 3.6A). 
Importantly, the untagged ATPase domain co-eluted with His-HSA-pHSA on a Ni-
NTA affinity column (Figure 3.6A,D).  The same results were obtained with TEV-
cleavable construct Sth1365-1097, lacking the HSA domain; Sth1365-1097 was soluble 
before and after TEV cleavage and the resulting untagged ATPase and His-pHSA 
fragments co-eluted on a Ni-NTA column (Figure 3.6B,D).  Taken together, these 
results support my prediction that the pHSA and ATPase domains of Sth1 interact 
with each other. 
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Figure 3.5 – Experimental approach to test for the pHSA-P1 interaction. 
Scheme depicting the TEV cleavage and co-purification assay designed here to 
test for intramolecular interactions between the HSA-pHSA and ATPase regions of 
Sth1. 
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Figure 3.6 – The pHSA domain interacts directly with P1. 
A-D) SDS-PAGE analysis (4-15% gradient gel) of constructs A) Sth1301-1097 , B) 
Sth1365-1097 and C) Sth1301-1097P1swap before cleavage (1), after cleavage (2) and after 
co-purification (3), as depicted in Figure 3.6.  D) Quantification of the amount of the 
Sth1 ATPase domain remaining soluble and associated with N-terminal His-tagged 
fragments after TEV cleavage (dark blue) and co-purification (light blue) for each 
construct.  The error bars represent the standard deviation from at least three 
independent experiments. 
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3.4 – The pHSA domain interacts directly with protrusion-1 
 Because mutations that suppress DArp7/9 lethality localize to the pHSA and 
P1 domains of Sth1 (Figure 3.4), these two regions of Sth1 might be expected to 
directly interact with each other.  To test this possibility, I swapped P1 in the TEV-
cleavable construct Sth1301-1097 with that of Rad54, a homologous SF2 ATPase that 
does not bind actin or Arps and therefore has a very different P1.  In the resulting 
construct (Sth1301-1097P1swap), Sth1 residues P646-P692 are replaced with Rad54 
residues P610-P644 (which is 12-aa shorter), such that the swapped region is 
flanked by sequences conserved in all remodelers that can thus be unequivocally 
aligned (Figure 3.4).  Importantly, the replaced sequence is mostly exposed in the 
structure of Rad54 (Durr et al., 2005), and the few residues that interact with the 
ATPase domain tend to be conserved in Sth1. 
As anticipated, the P1 substitution almost completely abolished the ability of 
His-HSA-pHSA to pull-down the ATPase domain on a Ni-NTA affinity column after 
TEV cleavage (Figure 3.6C,D).  What is more, the P1-swapped ATPase domain 
remained soluble after cleavage and separation from His-HSA-pHSA, implying that it 
is the exposure of surfaces on P1 that lowers the solubility of ATPase constructs 
lacking the pHSA domain.  These results suggest that at least in the absence of 
Rtt102-Arp7/9, the pHSA domain of Sth1 directly interacts with P1 in the ATPase 
domain.  Because these two regions are highly conserved within SWI/SNF 
remodelers (Figure 3.4), I predict that this interaction is conserved throughout the 
family, including in the human BAF complex. 
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3.5 – Rtt102-Arp7/9 regulates the pHSA-P1 interaction  
Since mutations in P1 and the pHSA domain restore the viability of DArp7/9 
yeast strains (Szerlong et al., 2008), and thus likely cause Sth1 to mimic the Arp-
bound conformation, I reasoned that binding of Arp7/9 to the HSA domain could 
regulate the pHSA-P1 interaction.  To test this possibility, the TEV cleavage and pull-
down assay described above was performed with construct Sth1301-1097 co-purified 
with Arp7/9 (Figure 3.7).  However, contrary to expectations, the majority of the 
ATPase domain (> 90%) remained soluble upon cleavage, and it co-eluted with 
Arp7/9-bound His-HSA-pHSA (Figure 3.8A,B).  Therefore, Arp7/9 alone has little 
effect on the pHSA-P1 interaction. 
In light of the conformational changes that Rtt102 promotes in Arp7/9 and its 
role in promoting the formation of a stable complex between the Arps and the Sth1 
ATPase domain, I reasoned that Rtt102 may be required for the Arps to regulate the 
intra-molecular interaction between the pHSA and P1 domains.  To test this 
hypothesis, I repeated the above assay with Sth1 in complex with Rtt102-Arp7/9 
(Figure 3.7).  Strikingly, the presence of Rtt102 substantially weakened the pHSA-P1 
intra-molecular interaction (Figure 3.8A,B).  Thus, approximately 23% of the ATPase 
was lost after TEV cleavage due to protein precipitation; as mentioned above, the 
ATPase domain in isolation has low solubility.  Furthermore, an additional 45% of the 
ATPase fragment was further lost after passage of the digested complex through a 
Ni-NTA affinity column, indicative of a substantial weakening of the pHSA-P1 
interaction.  These results suggest that Rtt102-Arp7/9 binding to the HSA domain of  
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Figure 3.7 – Experimental approach to test for regulation by the Arps. 
Scheme depicting the TEV cleavage and co-purification approach to test the effect 
of Arp7/9 binding on the pHSA-P1 interaction ±Rtt102. 
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Figure 3.8 – Rtt102-Arp7/9 weakens the pHSA-P1 interaction. 
A) SDS-PAGE analysis (12% gel) of Sth1301-1097 plus Arp7/9 or Rtt102-Arp7/9 
before cleavage (1), after cleavage (2) and after co-purification (3), as depicted in 
Figure 3.7.  B) Quantification of the amount of the Sth1 ATPase domain remaining 
soluble and associated with N-terminal His-tagged complexes after TEV cleavage 
(dark blue) and co-purification (light blue).  The error bars represent the standard 
deviation from at least three independent experiments. 
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Sth1 negatively regulates the interaction between the pHSA domain and the P1 
region of the ATPase domain. 
3.6 – Rtt102-Arp7/9 reduces the affinity of the ATPase domain for DNA 
The results described above suggested that the binding of Rtt102-Arp7/9 
produces a conformational change in Sth1, which in principle could affect DNA 
binding, since structural studies predict that P1 contacts the DNA (Durr et al., 2005).  
To test this possibility, I compared DNA binding to Sth1 alone and in complex with 
Rtt102-Arp7/9 using fluorescence anisotropy, as previously described (Malik et al., 
2011).  Here, I tested three Sth1 constructs: Sth1301-1097, comprising the HSA-pHSA 
and ATPase domains, Sth1365-1097, lacking the HSA domain, and Sth1388-1097, lacking 
the entire HSA-pHSA helix. 
Since the Sth1 enzyme is a DNA-dependent ATPase, to avoid nucleotide 
hydrolysis effects during the titrations, the experiments were performed with the non-
hydrolyzable ATP analog AMPPNP.  Finally, because the interaction with DNA is 
highly sensitive to the ionic strength (Zaitseva et al., 1999), the experiments were 
performed in 50 mM NaCl.  Sth1365-1097 and even Sth1388-1097, lacking 1/3 of the 
pHSA domain, are soluble and monomeric under these conditions, both alone and in 
complex with the purified double-stranded DNA used for the anisotropy assays 
(Figure 3.9), as illustrated here for construct Sth1388-1097 using multi-angle light 
scattering analysis in-line with size-exclusion chromatography (Figure 3.10).  In 
contrast, construct Sth1301-1097 was only soluble and monomeric when bound to 
Rtt102-Arp7/9, and therefore could not be reliably analyzed in isolation at such a low 
salt concentration. 
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Figure 3.9 – Oligonucleotide purification. 
A,B) Reverse-phase elution profiles of the complementary A) Watson and B) Crick 
strands of the 20-bp DNA duplex used in the MALS and anisotropy experiments 
presented in this thesis.  For both strands, an analytical run of the crude and 
purified oligonucleotides is shown. 
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Figure 3.10 – Sth1 forms a 1:1 complex with DNA. 
A) SEC-MALS analysis of the molecular mass of Sth1388-1097 with (marine blue) or 
without (navy blue) a 20-bp DNA duplex.  
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For the fluorescence anisotropy experiments, the fluorescin label was 
strategically attached to the 20-bp DNA duplex, since the DNA is much smaller than 
the Sth1 derivatives analyzed here, and will thus exhibit a greater change in tumbling 
rate upon complex formation (Favicchio et al., 2009).  Sth1365-1097, in which the 
pHSA-P1 interaction is preserved (Figure 3.6B,D), binds DNA tightly, with sub-
micromolar affinity, whereas Sth1388-1097 displays a nearly 2-fold lower affinity for 
DNA (KD 1.32 vs. 0.76 µM) (Figure 3.11A).  The two binding curves converge to 
nearly identical values for maximum anisotropy change, which is consistent with the 
small difference in size between the two constructs.  Although Sth1388-1097 is only 23-
aa shorter than Sth1365-1097, the region deleted is mostly highly conserved and 
includes several of the aforementioned DArp7/9 suppressor mutations (Figure 3.4).  
Therefore, I predict that this region is directly implicated in the interaction with P1, 
and has a role in regulating DNA access to the ATPase domain.  A more dramatic 
~7-fold drop in the DNA-binding affinity (KD 4.6 µM) was observed with the 
quaternary complex Rtt102-Arp7/9-Sth1301-1097 (Figure 3.11B).  As shown above 
(Figure 3.8A,B), the binding of Rtt102-Arp7/9 to the HSA domain significantly 
weakens the interaction between the pHSA and ATPase domains, which in turn 
appears to have the biological consequence of weakening the affinity of the ATPase 
for DNA. 
3.7 – Crystallization of the Sth1 ATPase domain 
In an effort to support the biochemical evidence showing a strong intra-
molecular interaction between the pHSA domain and the P1 region of Sth1, and to 
elucidate the structural basis for the high affinity of Sth1 for DNA promoted by this  
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Figure 3.11 – Rtt102-Arp7/9 binding reduces the affinity of Sth1 for DNA. 
 
A,B) DNA binding to A) Sth1365-1097 and Sth1388-1097 and B) Rtt102-Arp7/9-Sth1301-
1097 measured by fluorescence anisotropy.  Affinity values (KD) were obtained by 
fitting the data to a single-site hyperbolic binding isotherm.  Error bars represent 
the standard deviation from three measurements within one experiment, whereas 
the reported error values represent the standard deviation of the fits from three 
independent experiments. 
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auto-interaction, I set out to determine the crystal structure of Sth1.  Interestingly, 
when expressed in bacteria, the yield of Sth1 construct 301-1097 is quite poor, 
registering at roughly 1 mg of pure protein for every liter of culture.  Furthermore, the 
purified protein requires high salt (ie. 500 mM NaCl) to prevent precipitation and 
aggregation.  This is likely due to HSA domain, normally shielded by interaction with 
the Arps, being exposed.  Therefore, this construct is not an ideal candidate for 
large-scale crystallization trials.  Remarkably, deletion of the HSA domain to 
generate Sth1 construct 365-1097 results in a 25-fold increase in expression level.  
Since the pHSA-P1 interaction is fully retained in this construct (Figure3.6B,D), I 
reasoned that this Sth1 derivative represents a strong and biologically relevant 
candidate for crystallization.  Unfortunately, a high-throughput screen crystallization 
screen did not produce any hits.   
Next, I shifted my focus to Sth1 construct 388-1097.  Although this derivative 
lacks the N-terminal 18 aa region of the pHSA domain in which the DArp7/9 
suppressor mutations are clustered, the portion of the pHSA domain which is 
retained is highly conserved (Figure 3.4) and predicted to form a single alpha helix 
(Figure 2.2).  Therefore, a crystal structure of this Sth1 construct would be 
informative in showing how the ATPase core is regulated by the pHSA domain.  
Even at high concentrations of up to 30 mg/mL, Sth1388-1097  is mono-dispersed, 
running exclusively as a monomer as assayed by size-exclusion chromatography 
(Figure 3.12A).  Furthermore, MALDI-TOF analysis of the purified sample produces 
a single peak with a mass nearly identical to the predicted size of the construct 
(Figure 3.12B,C), indicating that the protein is highly stable.  Therefore, I performed  
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Figure 3.12– An Sth1 construct for crystallographic studies. 
A) Size-exclusion chromatography (SD-200, GE Healthcare) elution profile of Sth1 
construct 388-1097.  The elution volume of the protein is consistent with a 
monomeric species.  B) SDS-PAGE analysis (12%) of the fractions comprising the 
peak from A).  C) MALDI-TOF mass spectrum of the purified protein.  The 
agreement of the predicted and observed masses indicates the construct is highly 
stable.  
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extensive high-throughput crystallization trials of Sth1388-1097, both in isolation and in 
complex with the double-stranded DNA oligo used in the anisotropy assays 
described above. 
 For the Apo sample, clusters of small, needle-like crystals appeared in a 
condition with PEG 3350 as base precipitant roughly one week after a large scale 
crystallization screen (Figure 3.13A).  Encouragingly, I was able to reproduce the 
crystals by hand.  Interestingly enough, the crystals I produced using the hanging 
drop method were much larger than those in the initial hit, and had a thin, plate-like 
morphology (Figure 3.13B), whereas those I re-produced using the sitting drop 
method were far smaller.  I carried out further optimization by using the hanging-drop 
crystals as seeds in a micro-seed matrix screen (Obmolova et al., 2014), which 
identified a new condition, with a different PEG (5000 MME) as base precipitant, that 
generated large plate-like crystals with more thickness than the original ones (Figure 
3.13C).  Regrettably, the crystals did not diffract, neither using our laboratory’s home 
source nor at the new NSLS-II synchrotron source.  Ultimately, further rounds of 
seeding combined with additive screening may be required to generate well-ordered 
crystals which are amenable for high-resolution diffraction and structure 
determination.  
3.8 – Discussion 
Building on the previous chapter, in which Rtt102 was established as an 
important stabilizing factor for the Arp7/9 hetero-dimer, here I employed SAXS to 
investigate if Rtt102 also affected the conformation of the Sth1 catalytic subunit.  
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Figure 3.13 – Crystallization of Sth1. 
A) Initial crystals of Sth1388-1097 obtained using the sitting drop method.  The 
crystals are small and needle-like, forming many clusters in the drop.  B) Crystals 
of Sth1388-1097 reproduced using the hanging drop method. The crystals are larger, 
but quite thin.  They stain rapidly and robustly with JBS Bright Red (Jena 
Bioscience), indicative of protein crystals.  C) Optimized crystals of Sth1388-1097, 
obtained using the crystals from B) as seeds in a micro-seed matrix screen. A 
representative crystal plate, whose large face is perpendicular to the page, is 
surrounded by the red box. 
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Indeed, this work shows that Rtt102 promotes a transition from an extended to a 
more compact conformation of the Arp7/9-Sth1 subcomplex of the RSC remodeler.  
Given the large, roughly 100 Å difference in the maximum dimensions of the 
subcomplex (± Rtt102), it is unlikely that this dramatic effect can be fully accounted 
for by conformational changes in the Arps and the catalytic subunit, since these 
would have to be enormous to account for the observed change in dimensions.  A 
more reasonable explanation is that in the absence of Rtt102, since Arp7/9 has 
weaker affinity for the HSA domain, the Arp7/9 and Sth1 may not form a stable, 
constitutive complex.  Therefore, Rtt102 must be considered in any analysis of 
regulation of Sth1 structure and function by Arp7/9. 
To arrive at a molecular understanding of how Rtt102-Arp7/9 regulates Sth1, 
this work uses a novel biochemical approach to establish that the pHSA domain of 
Sth1 interacts with the P1 region of the ATPase domain, and that regulation of this 
interaction might be an important mechanism to fine-tune the activity of SWI/SNF-
family remodelers.  This finding adds to a growing list of evidence showing that 
domains adjacent to the ATPase domain regulate the activity of the catalytic subunit 
in several remodelers.  Thus, N-terminal chromodomains in Chd1 interact with and 
lock the ATPase domain in an inactive conformation (Hauk et al., 2010).  The AutoN 
and NegC regions of ISWI, N- and C-terminal to the ATPase domain, negatively 
regulate ATP hydrolysis and the coupling of ATP hydrolysis to productive DNA 
translocation, respectively (Clapier and Cairns, 2012).  Similarly, the N-terminal 
region of CSB negatively regulates its ATPase activity (Lake et al., 2010).  In 
SWI/SNF remodelers, the SnAc (Snf2 ATP coupling) domain positively regulates the 
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catalytic activity of the ATPase domain and may also interact with histones (Sen et 
al., 2011; Sen et al., 2013). 
During the preparation of this thesis, a structure of the Sth1 homolog Snf2 
from Myceliophthora thermophila was reported (Xia et al., 2016).  The structure 
comprises Snf2 residues Ala-458 to Gly-1128, corresponding to Sth1 residues Ser-
383 to Gly-1049.  Although large portions of the structure were not visualized, 
including parts of P1 and the linker between the pHSA and ATPase domains, the 
structure offers important clues; it reveals most of the pHSA domain (equivalent to 
Sth1 residues Ser-383 to Val-419) and a portion of the C-terminal SnAc domain 
(equivalent to Sth1 residues Asp-971 to Gly-1049).  Both, the SnAc and pHSA 
domains interact extensively with the ATPase domain and, consistent with our 
findings, the pHSA domain lies adjacent to P1.  The concurrence of our findings and 
high conservation of the interacting sequences lead me to speculate that the pHSA-
P1 interaction may be conserved throughout the actin/Arp-containing remodelers of 
the SWI/SNF family.  Importantly, the structure does not reveal the effect of the Arps 
on this intra-molecular interaction, which, in light of their important roles in vivo, is 
critical to our understanding of remodeler function.  
I further established here a regulatory mechanism that modulates the pHSA-
P1 interaction, and which could well be conserved throughout the SWI/SNF 
remodeler family.  I found that binding of Rtt102-Arp7/9 to the HSA domain of Sth1 
weakens the pHSA-P1 interaction, which in turn reduces the DNA-binding affinity of 
Sth1 approximately 7-fold.  Interestingly, a recent study found that binding of Rtt102-
Arp7/9 increases the efficiency of the Sth1 catalytic subunit of RSC, by allowing for 
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more efficient DNA translocation per ATP hydrolysis cycle despite an overall 
reduction in DNA-dependent ATPase activity (Clapier et al., 2016).  The same study 
found that a DArp7/9 yeast viability-restoring mutation in the P1 region had the same 
effect in the absence of Rtt102-Arp7/9.  Based on the results presented here, it is 
tempting to propose that the decrease in the affinity of the Sth1 ATPase for DNA, 
brought upon by the Rtt102-Arp7/9-dependent weakening of the pHSA-P1 
interaction, constitutes a mechanism for increased remodeler efficiency.  This 
scenario would be somewhat analogous to the way ATP binding weakens the affinity 
of myosin and dynein for their filamentous tracks in the cytoskeleton during their 
respective mechano-chemical cycles.  However, in the case of chromatin remodelers 
the molecular bases of this effect remain unresolved. 
New developments in the cryo-EM field may help elucidate the structural 
bases for the increase in remodeling efficiency of Sth1 by Rtt102-Arp7/9.  
Determining structures of Sth1 bound to nucleosomes ±Rtt102-Arp7/9 would be of 
great importance in this regard.  Given the intrinsic structural flexibility of the recA 
domains relative to one another (Durr et al., 2005; Hauk et al., 2010; Thoma et al., 
2005; Xia et al., 2016), one possibility is that pHSA-P1 interaction locks the ATPase 
in a conformation in which the recA lobes, while able to bind DNA with high affinity, 
are not able to efficiently translocate along the DNA.  Here, breaking of the pHSA-P1 
by the binding of Rtt102-Arp7/9 to the neighboring HSA domain could free the 
ATPase domain to adopt conformations more suitable for DNA translocation on 
nucleosomes.  Likely, the linker between the HSA and pHSA helices, which contains 
three of the afore-mentioned yeast viability-restoring mutations (Figures 2.2, 3.4), 
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serves as a hinge for Rtt102-Arp7/9-dependent conformational changes in Sth1.  
Ultimately, EM studies of the RSC subcomplex and its interactions with nucleosomes 
will be important in translating the mechanism proposed here to a more detailed 
understanding of the specific role of the Arps in the general remodeling mechanism.  
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CHAPTER 4: Materials and Methods 
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4.1 – Proteins 
All protein constructs for this work were amplified by PCR from a 
Saccharomyces cerevisiae genomic DNA library (Novagen).  Uniprot accession 
codes for the proteins expressed are Arp7, Q12406; Arp9, Q05123; Rtt102, P53330; 
Sth1, P32597; Snf2, P22082.  Table 4.1 lists the proteins expressed, expression 
plasmids, cloning sites, purification tags, and co-lysing strategies used for the 
assembly of RSC and SWI/SNF subcomplexes.  For Arp9 constructs, the 5¢-intron 
was removed.  For construct Sth1301-1097P1Swap, the Sth1 fragments 301-645 and 
693-1097 were separately amplified, then primer-extended to add S. solfataricus 
Rad54 residues 610-644.  A silent EcoRI site was introduced during extension to 
ligate the two Sth1 fragments.  
Most proteins were expressed in BL21-CodonPlus(DE3)-RIL cells 
(Stratagene) carrying additional plasmids for co-expression of two chaperones (cells 
were a generous gift of Dr. T. Sitar, Max Planck Institute).  Proteins fused to MBP 
were expressed in E. coli BL21(DE3) cells (New England Biolabs).  Transformed 
cells were grown in TB medium supplemented with 4% glycerol and antibiotics at 
37°C to an O.D. of 2.  Expression was induced with 1 mM IPTG and cells were 
grown for 14 h at 18°C (for the Arps, Rtt102, or MBP-fusion constructs of Sth1 and 
Snf2) or 22°C (for all Sth1 constructs bearing the ATPase domain).  The cells were 
harvested by centrifugation and stored at -80°C. 
 Trimeric and quaternary complexes were purified from mixed pellets (Table 
4.1).  For protein species bearing a His6-affinity tag, cells were resuspended in  
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Table 4.1 – Design and cloning of protein constructs 
Proteins and 
complexes Vectors and restriction sites 
Purification tag 
(N or C-
terminal) 
Cleavage 
site 
Monomeric  
Arp7 pRSF-Duet1 (NcoI, SalI) His6 (C) Thrombin  
Arp9 pRSF-Duet1 (NcoI, SalI) His6 (C) Thrombin  
Rtt102 pRSF-Duet1 (BamHI, SalI) His6 (N) TEV  
Sth1301-1097 pRSF-Duet1 (BamHI, SalI) His6 (N) TEV  
Sth1388-1097 pRSF-Duet1 (BamHI, SalI) His6 (N) TEV 
MBP-Sth1301-364 pMAL-c2X (BamHI, SalI) MBP (N) TEV 
MBP-Sth1301-387 pMAL-c2X (BamHI, SalI) MBP (N) TEV 
MBP-Snf2578-642 pMAL-c2X (BamHI, SalI) MBP (N) TEV 
MBP-Snf2578-665 pMAL-c2X (BamHI, SalI) MBP (N) TEV 
Dimeric  
 Arp7/9 pRSF-Duet1 (NdeI, XhoI)/(NcoI, SalI) Arp7–His6 (C) Thrombin 
Trimeric (mixed pellets of separately expressed proteins and binary complexes) 
Arp7/9- Sth1301-387 
pRSF-Duet1 (NdeI, XhoI)/(NcoI, SalI) 
pMAL-c2X (BamHI, SalI) Sth1-MBP (N) TEV 
Rtt102-Arp7/9 pRSF-Duet1 (BamHI, SalI) pRSF-Duet1 (NdeI, XhoI)/(NcoI, SalI) 
Rtt102–His6 
(N) TEV 
Arp7/9-Sth1301-1097 
pRSF-Duet1 (NdeI, XhoI)/(NcoI, SalI) 
pRSF-Duet1 (BamHI, SalI) Sth1–His6 (N) TEV  
Quaternary (mixed pellets of separately expressed proteins and binary complexes) 
Rtt102-Arp7/9-
Sth1301-387 
pET-Duet1 (NdeI, XhoI) 
pRSF-Duet1 (NdeI, XhoI)/(NcoI, SalI) 
pMAL-c2X (BamHI, SalI) 
Sth1–MBP (N) TEV  
Rtt102-Arp7/9-
Sth1301-1097 
pET-Duet1 (NdeI, XhoI) 
pRSF-Duet1 (NdeI, XhoI)/(NcoI, SalI) 
pRSF-Duet1 (BamHI, SalI) 
Sth1–His6 (N) TEV 
 
  
 96 
lysis buffer (20 mM HEPES pH 7.5, 300 mM NaCl, 5% glycerol, 25 mM imidazole 
and 4 mM benzamidine), lysed using a Microfluidizer apparatus (Microfluidics), and 
clarified by centrifugation.  The lysates were purified on a Ni-NTA affinity column 
(Qiagen) and washed extensively with lysis buffer.  Proteins were eluted with 250 
mM imidazole, and the His-tag was cleaved using TEV or thrombin proteases at 4°C 
in sample buffer (20 mM HEPES pH 7.5, 200 mM NaCl, 5% glycerol, 2 mM DTT and 
4 mM benzamidine).  Remaining, uncleaved protein was removed by re-purification 
through the Ni-NTA affinity column.  Proteins and complexes bearing the Sth1 
ATPase domain were then bound to a HiTrap Heparin HP column (GE Healthcare) 
equilibrated in sample buffer (20 mM HEPES pH 7.5, 200 mM NaCl, 5% glycerol, 
2 mM DTT and 4 mM benzamidine).  Proteins were eluted using a 200-800 mM 
NaCl gradient, concentrated, and additionally purified through a gel filtration 
Superdex-200 column (GE Healthcare) equilibrated in sample buffer. 
For protein species bearing an MBP-affinity tag, cells were resuspended, 
lysed, and clarified as above, followed by purification on an amylose affinity column 
(New England Biolabs).  Proteins were eluted with 10 mM maltose, concentrated, 
and purified by gel-filtration chromatography as above.  For the Arp7/9-Sth1301-387 
complex (+/- Rtt102), the MBP tag on Sth1 was cleaved with TEV protease prior to 
gel filtration.  To reconstitute the Rtt102-Arp7/9 ternary complex for crystallization, 
separately purified Rtt102 and Arp7/9 were mixed at a 2:1 molar ratio and purified 
through a SD-200 gel filtration column equilibrated in sample buffer (without 
benzamidine).  
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4.2 – Circular Dichroism 
The far UV spectra of Arp7, Arp9, Arp7/9 and rabbit skeletal actin were 
recorded at 25°C, using an Aviv Biomedical Model 410 Circular Dichroism 
Spectrometer (Aviv Biomedical, Inc.).  The protein concentration was 5 µM in all the 
experiments. Buffer conditions were either 10 mM phosphate pH 8.0, 150 mM KF, 
5% glycerol, 0.5 mM DTT for the Arps, or 5 mM phosphate pH 8.5, 0.2 mM CaCl2, 
0.2 mM ATP, and 0.5 mM DTT for actin. 
4.3 – Isothermal Titration Calorimetry 
ITC experiments were performed using a VP-ITC calorimeter (MicroCal) at 
20°C, with a duration of 20 s for each injection, and an interval of 5 min between 
injections.  Prior to each experiment, proteins were extensively dialyzed in sample 
buffer, so as to minimize any buffer mismatch artifacts that could give rise to noise 
and interfere with data analysis (Pierce et al., 1999).  For each experiment (as 
indicated in the figures), the concentration of the protein construct or complex being 
titrated was 50-80 µM and that of the binding partner in the cell was ~10-fold lower. 
For ATP-binding experiments, 2.5 mM MgCl2 was added to the sample buffer, and 
the concentration of ATP was 50 µM (for the complexes) or 500 µM (for the 
individual Arps).  The heats of binding were corrected for the small exothermic heats 
of injection resulting from injecting proteins into buffer.  Data were analyzed and 
fitted using the Origin program (OriginLab Corporation). 
4.4 – Nucleotide exchange assay 
Rtt102-Arp7/9 at 50 µM was extensively dialyzed in sample buffer 
supplemented with 2.5 mM MgCl2 and 50 µM 1,N6-etheno ATP (e-ATP, Invitrogen).  
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The exchange reaction was initiated by adding 0.6 mM ATP or ADP, and was 
monitored by measuring the decrease in e-ATP fluorescence at 410 nm (with 
excitation at 355 nm) with a Cary Eclipse Fluorescence Spectrophotometer (Varian) 
for 5 min.  The exchange reactions were corrected for dilution resulting from the 
addition of ATP or ADP into buffer, and normalized to the fluorescence recorded 
before the addition of nucleotide. 
4.5 – Crystallization and Structure Determination  
Flash-frozen aliquots of Rtt102-Arp7/9 at 10 mg/mL were thawed on ice and 
subjected to ultra-centriguation at 80,000 RPM for 30 minutes.  The complex was 
then supplemented with 1 mM ATP and incubated for 30 minutes on ice.  The 
sample was subsequently crystallized at 16°C using the sitting drop method.  
Needle-like crystals were obtained in drops consisting of a 1:1 (v/v) mixture of 
protein and well solution (20% (v/v) PEG 3350 and 200 mM ammonium sulfate).  
These initial crystals were used to streak-seed hanging drops consisting of a 1:1.2 
(v/v) mixture of protein and well solution (20% (v/v) PEG 3350, 170 mM ammonium 
sulfate and 17 mM EDTA).  The resulting larger crystals were flash frozen in liquid 
nitrogen, using as cryo-protectant 25% glycerol added to the crystallization solution. 
X-ray datasets were collected at 100 K on a Bruker X8 Prospector X-ray 
diffraction system, fitted with an IμS microfocus sealed-tube X-ray source, Apex II 
CCD detector, 4-circle Kappa goniometer and an Oxford Cryostream 700 liquid 
nitrogen cooling system.  The diffraction datasets were indexed and scaled with the 
Bruker program SAINT (version v8.34a).  A molecular replacement solution was 
obtained with the program Phenix (Adams et al., 2010), using as a search model 
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PDB entry 4I6M (the HSA domain was not included in the search).  Model building 
and refinement were performed with the programs Coot (Emsley et al., 2010) and 
Phenix.  The use of the program Rosetta (DiMaio et al., 2013) in combination with 
Phenix significantly accelerated the convergence of the refinement during the initial 
steps.  Composite omit maps (Fig. 3B) were calculated with the program Phenix, 
using the Refine option to remove model bias. 
4.6 – ATPase Assay  
Proteins at 5 nM were incubated with 1 mM ATP for 20 min at 22°C in 20 mM 
HEPES pH 7.0, 50 mM potassium acetate, 2.5 mM MgCl2, 0.1 mg/mL BSA, 200 µM 
MESG, and 1 unit of purine nucleoside phosphorylase.  The reactions were stopped 
by addition of 250 mM EDTA, and the phosphate release was determined by 
measuring the absorbance at 360 nm (Rieger et al., 1997).  For Rtt10-Arp7/9-
Sth1301-1097, the experiment was performed ±30 µM (nucleotide concentration) of the 
plasmid pRSF-Duet-1 (Novagen). 
4.7 – Small Angle X-Ray Scattering  
Data were collected at CHESS beamline F2 at 20°C, using 30 s exposures.  
Prior to each experiment, samples were extensively dialyzed in sample buffer.  To 
minimize radiation damage, samples were continuously oscillated inside the cuvette 
during data collection.  To control for potential aggregation effects, samples were 
analyzed at three different concentrations (1.0, 0.5, 0.25 dilutions of the maximum 
concentration).  The scattering profile and Guinier plot of each sample was 
determined as the average of ten independent buffer scans subtracted from that of 
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ten sample scans with the program BioXTAS RAW (Nielsen et al., 2009; Toft et al., 
2008).  Distance distribution functions were calculated using the program GNOM 
(Svergun, 1992).  Ab initio envelopes were generated by calculating twenty 
independent models with the program DAMMIF (Franke and Svergun, 2009), which 
were then averaged with the program DAMAVER (Volkov and Svergun, 2003) to 
produce a single average envelope. 
4.8 – TEV Cleavage and Co-Purification Assay  
A TEV protease recognition site was engineered between Sth1 residues 424 
and 432 by multiple round of site-directed mutagenesis (Quikchange, Agilent).  
These constructs were expressed, co-lysed with Arp7/9 and Rtt102-Arp7/9 to form 
the respective RSC subcomplex, and purified to homogeneity, as described in 
section 5.1.  Purified Sth1 constructs 6 µM (±Arp7/9 and Rtt102) were then 
incubated with 20 µg of TEV protease for 10 minutes at room temperature, then 
overnight at 4°C in co-purification buffer (20 mM HEPES pH 7.5, 500 mM NaCl, 5 % 
glycerol, 25 mM imidazole, 1 mM MgCl2 and 0.1 mM AMPPNP).  A 1-mL volume of 
the reaction was then incubated for 4 h at 4°C with 250 µL of Ni-NTA resin (Qiagen) 
equilibrated in co-purification buffer.  Unbound protein was flowed through a 
PolyPrep column (Bio-Rad), and the resin was washed with 5 mL of co-purification 
buffer.  The His-tagged, pHSA-containing fragment and any remaining associated 
ATPase domain were finally eluted with 1 mL of co-purification buffer, supplemented 
with 250 mM imidazole. 
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The samples were then analyzed by SDS-PAGE, and the Coomassie-stained 
bands were quantified densitometrically using the program ImageJ (Schneider et al., 
2012).  For experiments with Sth1 alone, the ATPase level after cleavage was set to 
1.  To account for loading differences (before and after co-purification), the loss of 
ATPase after co-purification on the nickel column was calculated by normalizing the 
intensities of the His-tagged N-terminal fragments and adjusting the intensities of the 
ATPase bands accordingly.  For experiments with Arp7/9, the ATPase levels were 
normalized using the intensities of Arp7 and Arp9 as an internal reference.  The 
normalized ATPase band intensities for the TEV-digested samples were divided by 
0.91, a factor accounting for the loss of intensity of the ATPase band upon TEV 
cleavage and the resulting reduction in mass. 
4.9 – Oligonucleotide Preparation  
Oligonucleotides (5′-TCCATGTCCATGGATACGTGG-3′ and 5’-
TCCACGTATCCATGGACAT GGA-3’, IDT Technologies) were dissolved in 0.1 M 
TEAA, pH 7 and heated at 95°C for 5 minutes to perturb potential secondary 
structure.  The oligonucleotides were then injected onto a Symmetry300 C18 column 
(Waters) equilibrated with 0.1 M TEAA pH 7.0 and purified on a 0-20% acetonitrile 
gradient.  Following cycles of lyophilization and resuspension in 50% ethanol to fully 
remove the TEAA and acetonitrile from reverse-phase purification, the oligos were 
resuspended in hybridization buffer (20 mM HEPES pH 7.5, 2.5 mM MgCl2 and 50 
mM NaCl).  Equimolar (100 µM) amounts of each strand were mixed at 95°C and 
annealed by slowly cooling to room temperature.  For anisotropy experiments, both 
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oligonucleotides were provided by the manufacturer with a fluorescein label at the 5’-
end. 
4.10 – Fluorescence Anisotropy  
Prior to titrations, a 1.5 mL volume of the double-stranded oligonucleotide (50 
nM) was equilibrated in anisotropy buffer (hybridization buffer supplemented with 5% 
glycerol, 1 mM DTT, 1 mM AMPPNP and 0.1 mg/mL BSA) for 30 min at 20°C.  The 
anisotropy of free DNA was recorded with a Cary Eclipse fluorescence 
spectrophotometer (Varian) by excitation at 485 nm and recording the average 
anisotropy between 515 and 520 nm.  Measurements were performed in triplicate.  
Sth1 (±Rtt102-Arp7/9), at ~40 µM and pre-equilibrated in anisotropy buffer, was 
titrated, and recordings were taken after 4 min of stirring. 
The changes in anisotropy were obtained by subtracting the anisotropy of 
free DNA from that of DNA-protein complexes.  Data were fitted to a single-site, 
hyperbolic binding isotherm with the program Igor (WaveMetrics) to obtain 
dissociation constants.  In order to correct for any potential polarization bias in the 
detector of the instrument, the G factor was calculated using 100 nM fluorescin 
dissolved in anisotropy buffer equilibrated for 30 min at 20°C. 
4.11 – Multi-angle light scattering (SEC-MALS) 
Sth1 construct 388-1097 at 100 µM was incubated with a 1.5-fold molar 
excess of the double-stranded oligo (described above) for 2 h at 20°C.  The complex 
was loaded onto a TSKgel SuperSW2000 column (Tosoh Bioscience) connected in-
line with a DAWN HELEOS MALS detector and an Optilab rEX refractive index 
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detector for mass analysis.  Molecular masses were calculated with the program 
Astra (Wyatt Technology). 
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CHAPTER 5: Conclusions and future directions 
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5.1 – Major findings 
 In this dissertation, my overarching goal was to understand at a molecular 
level how actin and Arps regulate their host chromatin-remodeling complexes.  The 
study was guided by my initial hypothesis that in SWI/SNF- and INO80-family 
remodelers, the HSA and pHSA domains directly interact with the central ATPase 
domain, and that actin/Arp binding to the HSA domain weakens this intramolecular 
interaction.  Using a well-defined subcomplex of the yeast RSC remodeler, 
consisting of the Sth1 catalytic subunit and auxiliary subunits Arp7, Arp9, and 
Rtt102, I employed a diverse set of biochemical, biophysical, and structural 
approaches in an effort to test this prediction.  This investigation produced the major 
findings, summarized below and in Figure 5.1. 
 The above hypothesis implied that there could be competition between the 
Arps and the ATPase domain for interaction with the HSA domain.  Therefore, I first 
carried out a thorough, quantitative investigation of how Arp7/9 binds the HSA 
domain, and whether the binding of Rtt102 to the Arps has a regulatory role in this 
process.  These experiments established Rtt102 as an important stabilizing factor for 
Arp7/9.  Rtt102 binding promotes a compact conformation of the Arp7/9 hetero-
dimer which interacts exclusively with the HSA domain of Sth1.  Furthermore, Rtt102 
binding promotes the high-affinity binding of ATP to a single site within Arp7/9, which 
the crystal structure of Rtt102-Arp7/9 revealed to be formed by the actin-like cleft of 
Arp7.  Taken together, ATP and Rtt102 thus stabilize a compact conformation of 
Arp7/9 required for full binding to the HSA domain. 
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Figure 5.1 – Model for RSC regulation by Rtt102-Arp7/9. 
Rtt102 promotes the high-affinity binding of Arp7/9 to the HSA domain.  This in 
turn causes the weakening of an intra-molecular interaction between the pHSA 
and P1 domains of Sth1, and a corresponding decrease by ~7-fold in the DNA-
binding affinity of the ATPase domain.  It is possible that the pHSA-P1 interaction 
locks the two-recA domains in a conformation more competent for DNA binding.  
ATP is constitutively bound to Arp7 throughout this regulatory process.   
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Having established the mechanisms through which Arp7/9 is incorporated 
into the RSC complex, I then focused on the elucidating the effects of the Rtt102-
Arp7/9 – HSA interaction on the structure and function of the ATPase domain.  
When bound to Rtt102, the complex of Arp7/9 with the Sth1 assumes a more stable, 
compact conformation, consistent with more stable binding to the HSA domain.  
Based on my initial hypothesis, I then designed a novel assay, combining classical 
proteolytic cleavage and pull-down approaches, to test whether the conserved pHSA 
and P1 domains interact in an Rtt102-Arp7/9-dependent manner.  I performed this 
assay with a series of Sth1 constructs and complexes, and discovered that in the 
absence of the Arps, the pHSA and P1 domains directly interact. The HSA domain 
does not contribute to this intra-molecular interaction.  Rather, Rtt102-Arp7/9 binding 
to the HSA domain results in a weakening of the interaction. 
In order to correlate these structural findings with function, I measured the 
binding to DNA of the same Sth1 constructs and complexes, and discovered that 
Rtt102-Arp7/9 binding leads to a seven-fold reduction in the affinity of the ATPase 
domain for DNA.  Therefore, the release of the pHSA-P1 interaction by the Arps 
appears to control DNA access to the central ATPase domain.  These results 
suggest a molecular mechanism for how actin and Arps may regulate their host 
remodelers, and thus this study represents a substantial contribution to the 
remodeling field.  Future work in applying these findings to other remodelers and in 
building upon the mechanism proposed here to understand how the Arps promote 
translocation on chromatin will further cement our understanding of the regulatory 
roles that actin and Arps play in chromatin remodeling.   
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5.2 – Regulation of the pHSA-P1 interaction as a general mechanism 
 The work showcased here was performed in the context of a subcomplex of 
the RSC remodeler.  To ensure that the regulatory effects I discovered occur in the 
context of the full complex, it would be interesting to generate a yeast strain in which 
the TEV recognition site has been introduced between the pHSA and ATPase 
domains of Sth1.  Performing the TEV-cleavage and pull-down assay on full-length 
Sth1 and RSC purified from these strains would provide a definitive answer to this 
question.  Another consideration is whether the regulatory mechanism uncovered 
here is retained in humans.  Interestingly, within the SWI/SNF-family, the pHSA and 
P1 domains are highly conserved (Figure 3.4), and this is in spite of the swapping of 
Arp7/9 for the Arp4/actin pair in the higher eukaryotic orthologs.  Therefore, the 
regulatory mechanism established in the RSC likely is very likely to be a feature of 
the human complexes as well.  Given the importance of the human ortholog of Sth1, 
Brg1, in human health and disease, applying the approaches described in this work 
to a similar, actin-related subcomplex of the human BAF remodeler will be a priority. 
Interestingly, the conservation of the pHSA and P1 domains across 
SWI/SNF- and INO80-family remodelers is not particularly high, yet just as in 
SWI/SNF, conservation is quite high within the INO80 family (Figure 5.2).  Since 
remodeler catalytic subunits are believed to have evolved from a common ancestor, 
it is thus possible that these domains may have evolved independently within the two 
families, and that the regulatory mechanism discovered here has a role in INO80  
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Figure 5.2 – INO80 pHSA and P1 domains are highly conserved. 
Shown here is a plot of sequence conservation scores calculated from eight 
representative sequences of catalytic subunits from INO80-family remodelers and 
plotted on the 478-714 region of budding yeast Ino80.  Note the particularly high 
conservation of the pHSA domain.  Also shown is a sequence alignment of the P1 
regions of these catalytic subunits.  The highly conserved P1 domain is delineated 
by the orange dashed line. 
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remodelers as well.  Therefore, extending this study to the INO80 family will be an 
important next step in our overall understanding of actin and Arp function.   
5.3 – A FRET approach to study the dynamics of regulation 
 The ability of remodelers to translocate along DNA and thus pump DNA 
around the histone octamer (Saha et al., 2002) necessitates the ability to fine-tune 
DNA-binding affinity throughout the remodeling process.  Given the importance of 
controlling the pHSA-P1 interaction in regulating DNA access to the catalytic 
ATPase domain, the subcomplex of RSC described here constitutes a promising 
system to study by fluorescent resonance energy transfer (FRET).  Indeed, a FRET 
approach has been used by my laboratory colleagues to study Arp2/3 complex 
activation (Boczkowska et al., 2014) and the mechanism of auto-inhibition and 
Cdc42-dependent activation of the important cytoskeletal protein IRSp53 (Kast et al., 
2014). 
Here, using the structure of Snf2 from Myceliophthora thermophila as a guide, 
single sites within the pHSA and P1 regions could be labelled with a FRET pair.  
Steady-state FRET would allow for a qualitative analysis of the conformational 
changes in the ATPase as a function of Rtt102-Arp7/9 binding.  Subsequent time-
resolved FRET (TR-FRET) experiments would facilitate the calculation of inter-probe 
distances, which could be used to monitor the remodeling reaction in real-time and 
tentatively model the Arp-dependent conformational changes in Sth1 during this 
process.  Interestingly, FRET approaches to study the activities of chromatin-
remodeling complexes have largely involved the labeling of DNA and histones as a 
strategy to monitor the conformational changes in the nucleosomal substrate (Yang 
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and Narlikar, 2007).  Therefore, the approach outlined above represents a novel way 
to investigate remodeler mechanisms, by monitoring the conformational changes in 
the catalytic subunit that control access to nucleosomal substrates. 
5.4 – Towards a structure of RSC bound to the nucleosome 
This work established that Rtt102-Arp7/9 binding to the HSA domain of Sth1 
results in a substantial decrease in the affinity of the ATPase domain for DNA.  This 
is consistent with a recent report that Rtt102-Arp7/9 binding reduces the DNA-
dependent ATPase activity of Sth1 (Clapier et al., 2016).  However, the same study 
also found that the Rtt102-Arp7/9 module renders Sth1 a more efficient translocase, 
such that even with reduced catalytic activity, the quaternary complex can more 
efficiently translocate along DNA, leading to increased nucleosome sliding and 
ejection (Clapier et al., 2016).  An important next step in the study of Sth1 regulation 
by the Arps will thus be to develop a model which relates the weakening of the 
pHSA-P1 interaction to these observed nucleosome remodeling outcomes.  In other 
words, understanding how the Arps affect the conformation of the Sth1 ATPase 
domain as it engages the nucleosome is of great importance.  A powerful approach 
in this effort will be to generate a cryo-EM structure of the RSC subcomplex bound to 
the nucleosome.  The RSC subcomplex I have purified is pure, monodispersed 
(Figure 5.3), and of sufficient abundance that grids can be made directly from gel-
filtration eluants without ever having to concentrate the sample.  Furthermore, the 
size of the complex, both in isolation and bound to the nucleosome, is sufficiently 
large for cryo-EM studies (Merk et al., 2016).  Therefore, the RSC subcomplex of  
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Figure 5.3 – A pure, monodispersed RSC subcomplex for EM studies. 
A) SDS-PAGE analysis (12%) of the quaternary complex of Rtt102-Arp7/9-
Sth1301-1097 after Ni-NTA, Heparin, and size-exclusion purification steps. B) 
Analytical size-exclusion chromatography (Superose-6, GE Healthcare) elution 
profile of the RSC subcomplex.  The elution volume of the protein is consistent 
with a 1:1:1:1 complex.   
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Rtt102-Arp7/9-Sth1301-1097 represents an ideal candidate for structural studies by 
cryo-EM.  Indeed, I have embarked on a collaboration with the laboratory of Dr. 
Andres Leschzinger at the University of California, San Diego with the goal of 
obtaining an all-important structure of this complex bound to the nucleosome. 
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